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ABSTRACT
Germline development in animals is closely coordinated with those aspects of 
physiology that are influenced by environmental conditions. The soma acts as a vehicle 
for the germline and plays a critical role in regulating its development and maintenance 
by providing systemic and local instructive signals. Investigating the relationship between 
soma and germline is essential for understanding the mechanisms of germline develop-
ment across animals and, in particular, in the context of human reproductive physiology. 
Planarians provide a unique system for studying somatic regulation of germline develop-
ment: they display remarkable plasticity in maintenance of their germline, with the ability 
to develop or dismantle reproductive tissues in response to systemic and environmental 
cues. The planarian nervous system plays a key role in systemic regulation of germ cell 
development through signaling molecules such as neuropeptide Y-8 (NPY-8). In this 
study, we explored different aspects of NPY-8 biosynthesis and signaling in planarians and 
expanded our work to examine the role of G protein-coupled receptors (GPCRs) in sys-
temic and local regulation of germ cell differentiation. First, we revealed the expression of 
NPY-8 in central and peripheral nervous systems of the planarian and used mass spectro-
metric methods to deduce the structure of endogenous NPY-8. We demonstrated that two 
neuropeptide processing enzymes, prohormone convertase 2 and peptidylglycine alpha-hy-
droxylating monooxygenase, are essential for planarian reproductive development, likely 
through post-translational modification of NPY-8. Next, we sought to identify the NPY-8 
receptor by genome-wide analysis of planarian GPCRs. We identified 566 putative planar-
ian GPCR genes and classified them into conserved and phylum-specific subfamilies. By 
functional analysis of a subset these genes, we found that neurally expressed neuropeptide 
y receptor-1 is the NPY-8 receptor and required for reproductive maturation of the planar-
ian. Additionally, we screened the complement of GPCRs with enriched expression in sex-
ual planarians and identified a chemoreceptor family member, ophis, that is required for 
germ cell differentiation. ophis is expressed in somatic cells of male and female gonads, as 
well as in accessory reproductive tissues. We have previously shown that somatic gonadal 
cells are required for male germline specification and maintenance in planarians. Howev-
er, ophis is not essential for germline specification or maintenance, and therefore, defines 
a secondary role for planarian gonadal niche cells in promoting germ cell differentiation. 
In addition to characterization of NPY-8 expression and biosynthesis, our studies uncover 
the complement of planarian GPCRs and reveal previously unappreciated roles for these 
receptors in systemic and local control of germ cell development.
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1CHAPTER 1: 
GENERAL INTRODUCTION
Flatworms (platyhelminthes) are the simplest phylum of animals that are bilat-
erally symmetrical and triploblastic (made of three germ layers). They inhabit a broad 
range of environments as free-living flatworms (Turbellaria) in salt water, fresh water, and 
wetlands, or in the body of other animals as parasites (Trematoda and Cestoda) (Buchs-
baum et al., 2013). Free-living planarians are known for their remarkable regenerative 
capacity that allows them to regrow lost body parts (Morgan, 1898). Most planarians are 
hermaphrodites that ordinarily reproduce by sexual cross-fertilization, although some 
undergo spontaneous fissioning (often seasonally or under stress conditions) (Newmark 
and Sánchez Alvarado, 2002). In sexual planarians (such as the model organism Schmidtea 
mediterranea studied in this work) a population of somatic stem cells (called “neoblasts”) 
gives rise to a germline that produces differentiating germ cells and mature gametes (New-
mark and Sánchez Alvarado, 2002). However, planarian germline develops in close associ-
ation with somatic tissues that in turn support and regulate germline development (Chong 
et al., 2013; Collins et al., 2010). This work explores different aspects of the molecular and 
cellular mechanisms facilitating the interaction between the germline and the soma in the 
planarian Schmidtea mediterranea.
Systemic regulation of germline development in animals
Reproductive function, including the development of the germline and accessory 
reproductive tissues, is closely coordinated with those aspects of physiology that are influ-
enced by environmental conditions (Hubbard et al., 2013). Whether in the context of hu-
man physiology or in a broad and basic exploration of animal biology, how environmental 
2and physiological conditions influence sexual developmental programs is a growing area 
of research interest. Hormones play key roles in modulating biological processes, includ-
ing reproduction, in nearly all multicellular organisms (Markov et al., 2009). How animals 
use peptide and steroid hormones to systemically regulate their reproductive function will 
be reviewed here.
In humans
The human reproductive system is regulated by hormones from the pituitary 
gland, the adrenal cortex, and the gonads (Hadžiselimović, 1983; Harris, 1955; Plant, 
2015). During puberty, the hypothalamus produces gonadotropin-releasing hormone 
(GnRH), which in turn stimulates the production and release of follicle stimulating 
hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary gland. FSH 
and LH (also known as gonadotropins) regulate gonadal function by stimulating gamete 
production as well as release of gonadal hormones. A negative feedback loop is initiated 
by the increased gonad hormone levels that eventually inhibit GnRH production.
Gonadotropins function differently between males and females. In males, FSH 
stimulates primary spermatocytes to undergo the first division of meiosis, forming sec-
ondary spermatocytes. FSH also enhances the responsiveness of the testes (via Sertoli 
cells) to sex hormones (androgens) such as testosterone, while its own production is 
inhibited by inhibin, released by the testes. LH stimulates production of androgens by 
the Leydig cells of the testes. In females, FSH promotes development of egg cells that are 
associated with somatic follicle cells. Much like in the male gonads, follicle cells inhibit 
FSH production through inhibin. LH also stimulates the development of ova, ovulation, 
and production of female sex hormones such as estradiol and progesterone. Sex hormones 
are steroid hormones that are responsible for expression of secondary sex characteristics 
in both sexes, and regulation of the menstrual cycle in females.
Other systemic hormonal systems regulating reproduction in humans include pro-
lactin and oxytocin. Produced by anterior pituitary, prolactin stimulates the production 
of milk in females, following childbirth. Prolactin itself is regulated by the hypothalamic 
hormones, prolactin-releasing hormone and prolactin-inhibiting hormone (likely do-
pamine). PRH stimulates the release of prolactin, while PIH inhibits it. Oxytocin is pro-
duced by posterior pituitary and stimulates (and is further stimulated by) uterine contrac-
tions during childbirth. Oxytocin also induces contraction of myoepithelial cells around 
milk-producing mammary glands, and in turn is stimulated by the suckling of an infant. 
3Current knowledge about human reproductive physiology suggests that it is generally 
dominated by three common themes: 1) positive feedback loops to reinforce some effects, 
2) negative feedback loops to limit other effects, and 3) responsiveness to external stimuli.
In roundworm (Caenorhabditis elegans)
Soma-germline interactions have been extensively studied in invertebrate model 
organisms. In C. elegans germ cell proliferation is dynamically regulated in response to 
external stimuli. For primordial germ cells (PGCs) to initiate proliferation in the larval 
stage L1 the larvae must feed, suggesting that a food-induced signal assists transcriptional 
activation of the quiescent germ cell (Schaner et al., 2003). In addition to starvation, high 
temperature or disruption of the DAF2/Insulin-IGF-like receptor (IIR) signaling can lead 
to L1 developmental arrest that includes stagnation of germ cell proliferation (Baugh and 
Sternberg, 2006). PGC response to nutrition is also modulated by spindle assembly check-
point gene mdf-1 (Watanabe et al., 2008). Reduced levels of mdf-1 expression ablate the 
responsiveness of germ cells to nutritional status. However, in mdf-1 knockouts, germ cells 
do not proliferate at all upon starvation, nor does the phenotype rescue after resumption 
of feeding in larvae, suggesting precise levels of mdf-1 are essential for germ cell develop-
ment (Watanabe et al., 2008).
Larvae that successfully complete L1, have to decide whether to continue normal 
development in a “reproductive” manner (the L2 molt), or enter a stress-resistant de-
velopmental arrest state called “dauer” (Fielenbach and Antebi, 2008). Dauer involves a 
block in proliferation that includes germ cells as well (Ren et al., 1996). A genetic screen 
to find mutants that inappropriately proliferate their germline during dauer revealed 
that, through AMP-activated protein kinase signaling, worms use AMP-to-ATP ratio to 
monitor cellular energy and regulate germ cell development accordingly (Narbonne and 
Roy, 2006). Once favorable environmental conditions are restored, worms can resume 
their normal development and expand their germline (Fielenbach and Antebi, 2008). In 
addition to several short-range signals (discussed later), systemic insulin (IIR-mediated) 
signaling is required for robust larval germline proliferation (Michaelson et al., 2010). 
Studies show that this is done through inhibition of transcription factor DAF-16/FOXO 
and is independent of the role of IIR in dauer formation. During nutritional stress, IIR 
responds to ins-3 and ins-33 (both somatic insulin-like ligands), resulting in amplification 
of the germline stem cell (GSC) pool. This effect is, however, only limited to larval stag-
es, and does not persist into adulthood (Michaelson et al., 2010). Although not much is 
known about systemic regulation of germline plasticity in adult C. elegans, studies have 
4implicated a nuclear hormone receptor, nhr-49, in the ability of adult worms to undergo 
starvation-induced reproductive diapause, during which they lose most of their germline 
but are able to regrow it upon resumption of feeding (Angelo and Van Gilst, 2009).
In fruit fly (Drosophila melanogaster)
A number of studies have implicated peptide hormones in Drosophila reproduc-
tive development. Much like in C. elegans, insulin signaling plays a major role in tissue-ex-
trinsic regulation of the germline (LaFever and Drummond-Barbosa, 2005; Ueishi et al., 
2009). Drosophila insulin-like peptides (DILPs) mediate ovarian response to nutrition: 
on a protein-poor diet or under reduced insulin signaling, ovarian stem cell division and 
differentiation rates are reduced and vitellogenesis is blocked (Drummond-Barbosa and 
Spradling, 2001). DILPs mainly originate from neurosecretory cells in the brain, ablation 
of which results in similar reduction or block in egg production and vitellogenesis (Cao 
and Brown, 2001; Ikeya et al., 2002). Further studies showed that GSCs receive DILP 
signals directly and in a niche-independent manner (LaFever and Drummond-Barbosa, 
2005). Similarly, reduced insulin signaling resulted in slower proliferation of male GSCs 
and fewer spermatocytes (Ueishi et al., 2009).
Steroid hormones, too, play critical roles in regulation of Drosophila physiology. 
Major steroid hormones in insects are ecdysteroids, also known as molting hormones, and 
are key factors in developmental transitions (Niwa and Niwa, 2014). The 1970s discovery 
that vitellogenesis in mosquito fat body is regulated by ovarian ecdysteroids lead to nu-
merous studies focused on ecdysone-dependent regulation of oogenesis (Hagedorn and 
Fallon, 1973; Hagedorn et al., 1975). Later, researchers found that another small molecule, 
a linear sesquiterpenoid called juvenile hormone (JH), acts as a gonadotropin to control 
reproductive function in Drosophila females (Koeppe et al., 1985). Further studies have es-
tablished that there is extensive cross-talk between JH and both insulin-like and ecdysone 
signaling pathways and they all act together to form a robust systemic endocrine system 
that modulates reproductive development and function in Drosophila (Jindra et al., 2013).
In other invertebrates
Although studies in laboratory models such as C. elegans and Drosophila have 
revealed a great deal of information about hormonal control of reproductive develop-
ment in invertebrates, researchers have looked into other invertebrate species to broaden 
their knowledge of the matter. The first invertebrate gonad-stimulating substance (GSS) 
5was identified in an echinoderm, the starfish Asterina pectinifera. This neural substance 
was able to stimulate production of a meiosis-inducing factor by the ovaries (Kanatani 
et al., 1969). GSS was later found to be a relaxin-like heterodimeric peptide produced 
by starfish radial nerves (Mita et al., 2009). GSS is functionally analogous to vertebrate 
(especially fish and amphibian) LH in that its action on the ovarian follicle cells induces 
the final maturation or meiotic resumption of the oocyte (Nagahama et al., 1995). More 
recently, an endocrine system involving insulin-like peptides (ILPs) and target of rapamy-
cin (TOR) has been uncovered that regulates reproductive development in coordination 
with nutritional status in the mosquito Aedes aegypti. The mosquito ILP, produced by the 
neurosecretory cells of the brain, specifically binds mosquito insulin receptor (MIR) and 
dose-dependently induces production of ecdysteroid by the ovaries. Interestingly, similar 
ecdysteroid production by the ovaries can be induced by bovine insulin, suggesting broad 
functional conservation (Brown et al., 2008; Riehle and Brown, 1999). This insulin/TOR 
pathway also modulates JH production to permit the normal development and matura-
tion in mosquitoes (Pérez-Hedo et al., 2013).
Other peptide hormones such as short neuropeptide F (sNPF) and ovary matur-
ing parsin (OVP) have been shown to promote ovarian development and vitellogenesis in 
locusts (Cerstiaens et al., 1999; Girardie and Girardie, 1996). RNA interference-mediated 
knockdown of ILPs in locusts slowed oocyte growth, but knockdown of their putative 
inhibitors, neuroparsins (NPs), promoted vitellogenesis (Badisco et al., 2011). Interesting-
ly, neuropeptides extracted from locust brain (likely ILPs) can stimulate steroidogenesis 
in previtellogenic ovaries of the blowfly, Phormia regina, again, pointing to a substantial 
degree of conservation among molecules involved in invertebrate gonadotropic hormon-
al systems (Manière et al., 2009). For all the scattered work done on other invertebrate 
species, research concerning invertebrate endocrine signaling is mostly focused on ecdys-
ozoan model organisms, pests, and disease-related insects. The shortage of data linking 
invertebrate hormones to germ cell development and gametogenesis in divergent species 
has hindered a comprehensive understanding of how animals utilize systemic signals to 
regulate their reproductive development.
Neuropeptide Y
Neuropeptide Y (NPY) is an evolutionarily ancient and highly conserved peptide 
that acts as a neurotransmitter or hormone to modulate the physiology of animals. NPY 
is a linear polypeptide containing an arginine (R) followed by an amidated hydrophobic 
6residue (usually tyrosine or phenylalanine) at its C-terminus. The amidated C-terminal 
residue was indeed the means of NPY isolation from porcine tissue extracts, along with 
many other biologically active peptides (Tatemoto and Mutt, 1978; Tatemoto et al., 1982). 
Unlike most other proteins, biological localization and activity of NPY were examined 
after its chemical discovery. NPY immunoreactivity was demonstrated widely in rat and 
human brains, mainly in the paraventricular hypothalamic nucleus, hypothalamic arcuate 
nucleus, suprachiasmatic nucleus, median eminence, dorsomedial hypothalamic nucleus, 
and paraventricular thalamic nucleus, and at lower concentrations, in many peripheral 
neurons (Adrian et al., 1983; Allen et al., 1983; Chronwall et al., 1985; Lundberg et al., 
1982).
Lundberg and Tatemoto (1982) were the first researchers to discover a biologi-
cal activity for NPY, showing its powerful peripheral vasoconstrictive effect. Later, NPY 
was implicated in numerous functions of the central nervous system including circadian 
rhythm, food intake, energy expenditure, seizures, hormone secretion, and control of 
reproduction (Clark et al., 1984, 1985; Kalra and Crowley, 1984; Levine and Morley, 1984; 
Marksteiner and Sperk, 1988; Stanley and Leibowitz, 1984). Kalra and Crowley (1984) 
showed that injection of NPY suppressed LH release in rat brains. NPY also inhibited syn-
aptic transmission in the hippocampus by blocking calcium influx at the nerve terminal, 
further proving that NPY is involved in systemic control of hormone release (Colmers et 
al., 1988).
NPY signaling in vertebrate reproduction
NPY is a key regulator of reproductive function in model vertebrates. Injection 
of NPY into sex steroid-primed ovariectomized rats induces secretion of LH and GnRH 
(Sabatino et al., 1990; Urban et al., 1996). In contrast, in intact rats NPY has an inhibitory 
effect on reproduction by suppressing the pituitary-gonadal axis (Pierroz et al., 1996). This 
effect is exacerbated under conditions of negative energy balance, when the endogenous 
hypothalamic NPY levels are high, suggesting that NPY is responsible for coordinating 
reproductive function with energy availability (Aubert et al., 1998).
Further insight has been obtained by generating knockouts of NPY or its recep-
tors (Y1, Y2, Y4, and Y5) in mice. NPY deletion by itself does not cause any reproductive 
phenotypes, perhaps due to ligand redundancy or genetic or signaling compensation, 
however, it does improve fertility in otherwise infertile ob/ob mice (Erickson et al., 1996). 
Mice without the Y1 receptor are reproductively normal under basal conditions, but show 
7increased LH production and seminal vesicle size after starvation, presumably due to 
elevated NPY levels (Pedrazzini et al., 1998). Deletion of the Y4 receptor results in elevat-
ed GnRH expression in forebrain neurons, together with higher testosterone levels and 
over-development of mammary glands in male and female mice, respectively (Sainsbury 
et al., 2002). No effects on the reproductive hormonal axis have been observed for the Y2 
and Y5 receptors suggesting these receptors do not play major roles in reproduction-relat-
ed effects of NPY in mammals.
In addition to mammalian models, NPY expression and function has been stud-
ied in a variety of other vertebrate species. Among teleosts, Kah and colleagues (1989) 
showed that NPY is present at high concentrations in telencephalon and diencephalon of 
the goldfish, as well as in nerve terminals closely associated with gonadotropin-secreting 
cells of the pituitary. They also showed that in vitro treatment of anterior lobe fragments 
with NPY induces secretion of gonadotropin. Levels of NPY in goldfish telencephalon are 
in turn modulated by the steroid hormones testosterone and estradiol (Peng et al., 1994). 
Later, it was shown that in vivo treatment with NPY induced secretion of gonadotropins 
in the rainbow trout Oncorhynchus mykiss and the common carp Cyprinus carpio (Breton 
et al., 1991). In a variety of other teleost species, NPY acts within the hypothalamic-pi-
tuitary-gonadal (HPG) axis to coordinate reproduction with feeding and energy balance 
(Shahjahan et al., 2014; Subhedar et al., 2005). Overall, NPY appears to act in favor or 
against promoting reproduction, depending on the conditions of the experiments, and its 
role in reproductive function is far from understood.
NPF signaling in invertebrates
Many invertebrate neuropeptides are encoded by genes that are likely to be evo-
lutionarily related to mammalian neuropeptide genes (Nässel and Wegener, 2011). This 
evolutionary conservation has been proposed, not only for the neuropeptides, but also for 
their receptors and the physiological function of their interaction (Brogiolo et al., 2001; 
Husson et al., 2007; Nässel and Wegener, 2011; Nässel and Winther, 2010; Rewitz et al., 
2009). Ancestral homologs of NPY in invertebrates often have a phenylalanine (F) C-ter-
minal residue and are thus called NPFs. The first invertebrate NPFs were identified in the 
tapeworm Moniezia expansa (Maule et al., 1991). Later, other NPFs were identified in 
mollusks like Helix aspersa and Aplysia californica (Leung et al., 1992; Rajpara et al., 1992). 
It is worth noting that invertebrate short NPFs (sNPFs), while often acting on the same or 
similar receptors as NPFs, do not seem to be related to the ancestral NPY genes and their 
naming is misleading and unfortunate (Nässel and Wegener, 2011).
8Garczynski et al. (2002) identified the first invertebrate NPF receptor (DmNPFR1; 
CG1147) in Drosophila with significant similarity to mammalian NPY receptors, especial-
ly the Y2 receptor (Larhammar and Salaneck, 2004). Other putative receptors were later 
identified in several other insects, including Tribolium, Nasonia, and Anopheles, and the 
snail Lymnaea stagnalis (Garczynski et al., 2005; Hauser et al., 2008, 2010; Tensen et al., 
1998). Drosophila and Anopheles NPF receptors showed specific binding affinity to en-
dogenous NPFs in radioligand binding assays (Garczynski et al., 2002, 2005). Garczynski 
and colleagues (2002) also showed that NPFR1 mRNA is localized to a number of cells in 
the midgut and neurons in the brain and ventral nerve cord of the third instar larva. In C. 
elegans NPR-1 is structurally related to the NPF receptors in Lymnaea and insects, as well 
as the mammalian NPY receptors (de Bono and Bargmann, 1998). However, the ligands 
activating NPR-1 (derived from flp-18 and flp-21) are RFamides rather than NPFs (Rogers 
et al., 2003). Thus, it appears that the C. elegans genome does not encode all the compo-
nents of a true NPY/F signaling pathway.
In Drosophila, NPF signaling has been implicated in a variety of physiological 
functions, including feeding, energy homeostasis, stress response, ethanol sensitivity, and 
learning (Nässel and Wegener, 2011). As far as reproduction is concerned, several studies 
have revealed the role of NPF in behavioral aspects of reproduction, but not yet in relation 
to reproductive and germline development (Nässel and Winther, 2010). In C. elegans, al-
though no bona fide NPFs seem to be present, NPR-1 has been shown to function to reg-
ulate feeding and oxygen sensing (de Bono and Bargmann, 1998; Rogers et al., 2006). In 
mollusks, NPY has again been implicated in feeding behavior and energy consumption. In 
Aplysia, in contrast to mammals and Drosophila, NPY promotes the sense of satiation and 
prevents feeding (Jing et al., 2007). To add to the confusing picture, in the snail Lymnaea, 
increase in NPF does not alter food intake, but does suppress energy consumption (de 
Jong-Brink et al., 2001). The snail NPF-expressing neurons indeed have axonal extensions 
running close to insulin-producing and ovulation hormone-releasing neurons, supporting 
the connection between NPF and reproductive function (De Lange et al., 1997).
In flatworms, NPF homologs were first identified in the central nervous system 
(CNS) and near the peripheral muscles of the cestode M. expansa (Maule et al., 1992). 
Later, NPF immunoreactivity was found in the central and peripheral nervous systems of 
several other free-living and parasitic flatworm species (Johnston et al., 1995; Skuce et al., 
1990). Although no definitive NPF receptor has yet been identified in flatworms, NPF can 
inhibit forskolin-induced cyclic AMP (cAMP) in Schistosoma and Dugesia tissue homog-
enates (Humphries et al., 2004; Zamanian et al., 2012). Like most neuropeptides, NPYs 
9are ligands for G protein-coupled receptors (GPCRs). Genome-wide analysis of planarian 
GPCRs, and particularly neuropeptide receptors, will reveal the family of NPY receptor 
homologs in this phylum. Study of planarian NPYs and their receptors will provide broad 
insights into the conservation of NPY signaling mechanisms and functions across ani-
mals.
Means of signal transduction: G protein-coupled receptors
GPCRs are the largest and most versatile superfamily of cell surface receptors 
in animals. They are involved in a myriad of eukaryotic signal transduction and stimu-
lus-response pathways, in addition to structural and transport roles (Siehler and Milligan, 
2010). Despite their versatility in responding to a range of molecules that include biogenic 
amines, peptides, odorants, and neurotransmitters, GPCRs are defined by a core domain 
of seven transmembrane (TM) α-helices, extracellular domains that interact with ligands 
and external structures, and intracellular domains that participate in initiation of down-
stream cellular events. GPCRs are among the most extensively studied groups of proteins 
in mammals, however, hundreds of them remain uncharacterized (Tang et al., 2012). In 
planarians, hundreds of GPCRs have been identified by in silico methods (Zamanian et 
al., 2011), but the function of these genes in various physiological functions (particularly 
in reproduction) remains unknown.
GPCRs play critical roles in sexual reproduction, guiding germ cell migration, 
mediating hormonal regulation of gamete development, and facilitating the function of 
accessory reproductive tissues. For example, a complex network of peptidergic neurons 
in the mammalian hypothalamus controls the release of pituitary gonadotropins that 
systemically regulate gonadal function. GPCRs mediate various short- and long-range 
communication events in this hormonal cascade, whether the target is another neuron or 
a gonadal cell. Mutations in several of these GPCRs and their ligands are associated with 
hypogonadotropic hypogonadism and other reproductive disorders (Noel and Kaiser, 
2011). GPCRs that act as receptors for follicle-stimulating hormone (FSH), luteinizing 
hormone (LH), gonadotropin-releasing hormone (GnRH), kisspeptin, prokineticin, and 
tachykinin play essential roles in systemic regulation of gonadal function in mammals 
(Cole et al., 2008; Messager et al., 2005; Millar et al., 2004; Topaloglu et al., 2008; Tsut-
sumi et al., 1992). Despite extensive genetic information and molecular studies in mam-
malian models, much remains to be learned about the role of GPCR signaling in sensing 
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physiological and environmental cues and the evolutionary conservation of these mecha-
nisms in regulating reproduction across metazoans.
GPCRs also facilitate germ cell differentiation and maturation cell autonomously. 
CXCR4 in vertebrates and Tre1 in Drosophila enable chemokine-guided migration of pri-
mordial germ cells (PGCs) early in development (Knaut et al., 2003; Kunwar et al., 2003; 
Molyneaux et al., 2003). Other olfactory, adhesion-like, and secretin-like GPCRs and their 
signaling partners are required for the maintenance and proliferation of germline progen-
itors and stem cells as well as gamete morphogenesis (Agnese et al., 2010; Davies et al., 
2004; Goto et al., 2001; Pesce et al., 1996; Schneider and Spradling, 1997; Vaudry et al., 
2000). In many cases, however, GPCR ligands, signaling partners, and functional mecha-
nisms are far from understood.
Local (niche) regulation of germ cell development
In addition to complex organism-wide hormonal networks that coordinate ger-
mline function with the environment, short-range and local signals also affect the devel-
opment and function of germ cells. In fact, germ cells depend on nearby somatic cells for 
survival, self-renewal, adopting sexual identity, differentiation, and function (Xie, 2008). 
Somatic cells also form gonadal structures, providing a microenvironment, or a “niche”, 
that protects germ cells and supports their growth (Jemc, 2011). Schofield (1978) first 
proposed the concept of stem cell niche with regards to hematopoietic stem cells. Since 
then, various other kinds of stem cells, and consequently, their niche environment have 
been discovered, including the germ cell niche (Xie and Spradling, 2000). Somatic cells of 
the gonad also participate in the process of germ cell differentiation (Jemc, 2011). Much 
of what is known about the role of the somatic gonad in germ cell development has come 
from examination of Drosophila somatic gonadal cells, C. elegans distal tip cells (DTCs), 
and the spermatogonial stem cell niche in mice.
Somatic cells in the Drosophila ovary and testis
In Drosophila, primordial germ cells (PGCs) and somatic gonad precursor cells 
(SGPs) are the two components of gonad formation. At stage 12, PGCs migrate bilaterally 
towards SGPs, forming the primordial gonad (Boyle and DiNardo, 1995). Soon after that, 
SGPs begin ensheathing PGCs and continue to do so throughout development (Decot-
to and Spradling, 2005; Jenkins et al., 2003). Later in embryogenesis (around stage 17) 
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a group of 10–12 anterior SGPs form a structure called the hub, which persists through 
adulthood and regulates the GSCs (Aboïm, 1945; Gönczy et al., 1992; Hardy et al., 1979). 
The hub cells act as a niche by providing cell adhesion and necessary signals to the GSCs. 
Multiple adhesion molecules are expressed within the hub, including fasciclin 3, Drosoph-
ila E-cadherin (DE-cad), and Drosophila N-cadherin (DN-cad) (Kawase et al., 2004; Le 
Bras and Van Doren, 2006; Yamashita et al., 2003). The hub cells also express the cyto-
kine-like ligand unpaired (UPD) that promotes GSC maintenance and adhesion through 
JAK-STAT signaling (Kiger et al., 2001). Similar events occur in Drosophila ovaries as well. 
At the apical end of each ovariole (called the germarium), GSCs interact with cap cells via 
adherens junctions (Asaoka and Lin, 2004; Song et al., 2002).
Similar to male GSCs, female Drosophila GSCs are ensheathed by somatic cells 
called escort cells (Decotto and Spradling, 2005). Once established at the niche, GSCs 
can divide to give rise to more GSCs or daughter cells, called cystoblasts (Spradling et al., 
1997). Maintenance of the GSCs is dependent on signals from cap cells such as bone mor-
phogenic proteins (BMPs), decapentaplegic (DPP), and glassbottomed boat (GBB) (Li and 
Xie, 2005). These signals are often involved in preventing GSC differentiation as long as 
contact with the niche is preserved (Chen and McKearin, 2003). In both testes and ova-
ries, differentiating germ cells are surrounded by other specialized somatic cells called cyst 
and escort cells, respectively. These cells isolate germ cells from their environment and 
support them throughout differentiation, however, the molecular basis of their function is 
not completely understood (Xie, 2008).
Sertoli cells of the mouse testis
In the mouse testis, specialized somatic cells called Sertoli cells surround sper-
matogonial stem cells (SSCs) that are located near the seminiferous tubule basement 
membrane. These somatic cells not only regulate self-renewal of the SSCs, but also sup-
port the germ cells throughout their maturation process. Adjacent Sertoli cells form tight 
junctions to isolate SSCs from the environment, i.e., mainly the blood vessels and the 
lumen of seminiferous tubule (Xie, 2008). Other somatic components contributing to 
the testis niche are peritubular myoid cells outside of the basement membrane and the 
Leydig cells that act as endocrine signaling centers within the testis interstitium. Sertoli 
cells are involved in initiating spermatogonia differentiation by providing the KIT ligand, 
activating the c-kit receptor in SSCs (Rossi et al., 1991; Yoshinaga et al., 1991). Sertoli cells 
also express the glial cell line-derived neurotrophic factor (GDNF) that activates Ret and 
GFRα1 receptors to promote maintenance and self-renewal of SSCs (Hofmann et al., 2005; 
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Kubota et al., 2004; Meng et al., 2000). Vascular-associated testis niche also plays key role 
in maintenance and differentiation of spermatogonial cells. Live fluorescent imaging of 
mouse testes has demonstrated that undifferentiated spermatogonia preferentially local-
ize near the blood vasculature surrounding seminiferous tubules (Yoshida et al., 2007). 
Despite characterization of several signaling pathways contributing to SSC maintenance, a 
comprehensive picture of the cellular and molecular function of somatic gonadal niche is 
far from achieved.
Planarians as a model to study germ cell development
For centuries, planarians have been the focus of many scientific studies inspired by 
their extraordinary ability to regenerate lost body parts (see Brøndsted, 1969). However, 
it was not until the development of molecular biology tools and genomic resources that 
these flatworms claimed their new status as a model for regeneration, stem cell, and germ 
cell biology. It is now known that their regenerative capacity is largely due to a popula-
tion of pluripotent adult stem cells called neoblasts that can proliferate and differentiate 
into all tissue types (Baguñà, 1976; Baguñà et al., 1989; Reddien and Sánchez Alvarado, 
2004; Wagner et al., 2011). Planarians are also interesting from the perspective of germ 
cell biology and reproductive development. Both sexual and asexual planarians produce 
a germline from somatic tissues through inductive specification (Extavour and Akam, 
2003; Wang et al., 2007). This de novo germline specification can occur during embry-
onic development or when planarians regenerate from somatic tissues (Morgan, 1901). 
This phenomenon has been revisited more recently, demonstrating that GSCs expressing 
the early germ cell marker Smed-nanos (nanos) reappear in regenerating head fragments 
(initially devoid of germ cells) between 1 to 2 weeks post-amputation (Wang et al., 2007). 
These observations suggest that planarians, like mammals and many basal animals, spec-
ify their germline through inductive signals rather than the effect of maternally deposited 
determinants (Extavour and Akam, 2003; Juliano and Wessel, 2010).
External influences in germline development in flatworms
Planarians can develop or dismantle their reproductive tissues in response to 
systemic and environmental cues such as body size, nutritional status (Miller and New-
mark, 2012), and season (Curtis, 1902). Upon starvation or severe injury, planarians are 
capable of reversibly disassembling their reproductive system, presumably to curb met-
abolic demand or to prepare for body-wide tissue remodeling (Newmark and Sánchez 
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Alvarado, 2002). Upon amputations that entirely remove the reproductive system, the 
remaining head fragments can respecify germ cells and reproductive structures de novo 
(Morgan, 1901). Dynamic regulation of germline development is not just a free-living 
flatworm feature; parasitic members of the phylum Platyhelminthes are equally impres-
sive with regards to their reproductive development, managing to maintain reproductive 
potential throughout the many stages of their life cycle and reaching sexual maturity at the 
appropriate time and place within the suitable host (Collins et al., 2013; Kunz and Werner, 
2001). Moreover, female reproductive development in dioecious Schistosoma parasites re-
quires pairing with (and presumably external signals from) a male counterpart (Erasmus, 
1973; LoVerde and Chen, 1991; LoVerde et al., 2009). In fact, single-sex infection exper-
iments with female schistosomes results in underdeveloped ovaries and accessory repro-
ductive tissues. These underdeveloped reproductive organs are, however, able to regrow 
once the male-deprived female is paired with a male worm (Clough, 1981).
Our genome-wide analysis of planarian neuropeptides revealed that an NPY ho-
molog, npy-8, is required for achieving and maintaining reproductive maturity in planar-
ians (Collins et al., 2010). While npy-8 appears to be neurally expressed, its expression, 
processing, and signaling mechanism remain unknown. More recently, a nuclear hormone 
receptor, Smed-nhr-1 (nhr-1), expressed in the somatic accessory reproductive structures, 
has been shown to be required for germ cell differentiation and reproductive maturation 
of planarians (Tharp et al., 2014). Also, a DM-domain containing transcription factor, 
Smed-dmd-1 (dmd-1), has been identified as a marker of presumptive planarian testis 
niche cells (Chong et al., 2013). Expression of dmd-1 in somatic testis cells is essential for 
specification and maintenance of planarian germline stem cells (GSCs). Collectively, pre-
vious studies indicate that systemic and local cues play a fundamental role in regulating 
planarian reproductive development; however, the identities and mechanisms of function 
of most of such signals remain unknown.
Conclusion
Germ cells are indispensable for continuity and evolution of sexually reproducing 
species. To ensure their proper function, animals have mechanisms in place to coordi-
nate germ cell development with physiological and environmental conditions. Much has 
been learned about this through studies conducted in classical model organisms, how-
ever, those models only represent a small fraction of the strategies adopted by animals to 
regulate their reproductive function. Because of its reproductive plasticity and availability 
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of numerous functional genomics tools, we used the planarian Schmidtea mediterranea 
as a model to study regulation of germ cell development and reproductive function in 
flatworms. We performed functional screens of planarian neuropeptides to discover 
hormonal pathways involved in germ cell development. We then complemented that work 
with a genome-wide analysis of planarian GPCRs that revealed receptors involved in such 
hormonal pathways. What we learned from the planarian can also guide future studies on 
parasitic flatworms with human health-related significance.
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CHAPTER 2: 
PROCESSING, LOCALIZATION, AND REPRODUCTIVE 
FUNCTION OF PLANARIAN NEUROPEPTIDE Y-8*
Genome-wide analyses in our laboratory have identified a cohort of planari-
an genes that encode neuropeptides (Collins et al., 2010). Planarian neuropeptides are 
expressed in a variety of tissues, mainly in the nervous system. How these neuropep-
tides modulate the development and function of reproductive tissues is an interesting 
area of research. We have shown that a neuropeptide Y homolog, NPY-8, is required 
for reproductive maturity of the planarian. However, the structure of endogenous NPY-
8 and its biosynthesis pathway is unknown. In this chapter, we characterize the amino 
acid sequence and post-translational modifications of the bioactive NPY-8 and reveal its 
expression in the central and peripheral nervous systems of the planarian using specific 
polyclonal antibodies. We then explore the potential role of two neuropeptide-processing 
enzymes, a prohormone convertase and a peptidylglycine alpha-hydroxylating monooxy-
genase, in the processing and activation of NPY-8 in vivo. Finally, we show that protone-
phridial and intestinal cells can internalize synthetic NPY-8 peptides, suggesting a role for 
them in neuropeptide signaling or extracellular peptide elimination.
Introduction
Neuropeptide Y (NPY) is an evolutionarily ancient and highly conserved peptide 
that acts as a neurotransmitter or hormone to modulate the physiology of animals (Tate-
moto, 2004). While the biochemistry and physiological roles of NPY have been studied 
extensively in vertebrates and, to a lesser extent, in Drosophila, understanding the diversity 
*  Mass spectrometry experiments presented in Figure 2.5 were performed in collaboration with 
Elena V. Romanova from Dr. Jonathan V. Sweedler’s laboratory, UIUC.
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and common features of NPY biology requires studies in a wider variety of animals. 
However, our ability to unify what we learn about NPY in model organisms from diver-
gent metazoan phyla is subject to an assumption of biological conservation that needs to 
be supported at various levels, including: 1) NPY gene structure and sequence homology, 
2) its spatio-temporal expression, 3) its post-translational modifications, and 4) its cellular 
and developmental functions.
Like many other neuropeptides, NPY is the final product of elaborate enzymatic 
processing of a proneuropeptide that occurs within secretory vesicles of the cell in which 
it is produced (von Hörsten et al., 2004; Sossin et al., 1989). Bioactive NPY is a linear 
polypeptide containing an arginine (R) followed by an amidated hydrophobic residue 
(typically tyrosine, Y, or phenylalanine, F) at its C-terminus–a feature that facilitated its 
original chemical isolation (Tatemoto and Mutt, 1978; Tatemoto et al., 1982). NPY immu-
noreactivity has been demonstrated widely in rat and human brains, mainly in the para-
ventricular hypothalamic nucleus, hypothalamic arcuate nucleus, suprachiasmatic nucle-
us, median eminence, dorsomedial hypothalamic nucleus, and paraventricular thalamic 
nucleus, and at lower concentrations, in many peripheral neurons (Adrian et al., 1983; 
Allen et al., 1983; Chronwall et al., 1985; Lundberg et al., 1982). Among teleosts, NPY is 
present at high concentrations in telencephalon and diencephalon of the goldfish, as well 
as in nerve terminals closely associated with gonadotropin-secreting cells of the pituitary 
(Kah et al., 1989). Ancestral homologs of NPY in invertebrates usually have a phenylala-
nine (F) C-terminal residue and are thus called NPFs. Invertebrate NPFs were first iden-
tified in the CNS and near the peripheral muscles of the tapeworm M. expansa (Maule et 
al., 1991, 1992), and later in mollusks (Leung et al., 1992; Rajpara et al., 1992) and the fruit 
fly (Brown et al., 1999). In all cases, the primary source of NPY peptides appeared to be 
the central and peripheral nervous systems.
Biological activity of NPY was first discovered in relation to its sympathetic and 
peripheral vasoconstrictive effects (Lundberg and Tatemoto, 1982). Since then, NPY has 
been implicated in numerous functions of the central nervous system including circadi-
an rhythm, food intake, energy expenditure, seizures, hormone secretion, and control of 
reproduction (Clark et al., 1984, 1985; Kalra and Crowley, 1984; Levine and Morley, 1984; 
Marksteiner and Sperk, 1988; Stanley and Leibowitz, 1984). NPY is a key regulator of 
reproduction in vertebrates (Breton et al., 1991; Pierroz et al., 1996; Sabatino et al., 1990; 
Shahjahan et al., 2014; Subhedar et al., 2005; Urban et al., 1996) and may be involved 
in coordinating reproductive function with energy availability (Aubert et al., 1998). In 
Drosophila, NPF signaling has been implicated in feeding, energy homeostasis, stress 
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response, ethanol sensitivity, and learning (Nässel and Wegener, 2011). As far as reproduc-
tion is concerned, several studies have revealed the role of NPF in behavioral aspects of 
Drosophila reproduction, but not yet in relation to fly reproductive and germline develop-
ment (Nässel and Winther, 2010). In mollusks, too, NPY has been implicated in feeding 
behavior and energy consumption, but its role in reproductive development is unclear 
(De Lange et al., 1997; Jing et al., 2007; de Jong-Brink et al., 2001). Overall, NPY has a 
deeply conserved orexigenic effect across animals, however, it appears to act to promote 
or inhibit reproduction, depending on the conditions of the experiments, and a conserved 
reproductive function is far from established.
We previously identified 11 NPY-like genes in the planarian Schmidtea mediterra-
nea and showed their expression in patterns consistent with central and peripheral neu-
rons (Collins et al., 2010). We also showed that the neurally expressed planarian NPY-8 
is required for male and female germ cell differentiation and reproductive maturity of the 
worm and acts via a planarian NPY receptor homolog, NPYR-1 (See Chapter 3) (Collins 
et al., 2010; Saberi et al., 2016). To further support conservation of NPY biosynthesis in 
flatworms, we focused here on NPY-8 tissue expression and biosynthesis. We used novel 
polyclonal antibodies to characterize expression of NPY-8 in the planarian nervous sys-
tem. By purifying the endogenous peptide and subsequent mass spectrometric analyses, 
we characterized the structure of NPY-8. We further explored the role of a prohormone 
convertase and an amidating enzyme in a putative NPY-8 processing pathway. Finally, we 
purified a heterogeneous population of NPY-8-interacting cells from live-cell dissociates 
and developed a novel computational method to resolve two cell types within that pop-
ulation that may have a role in responding to NPY-8 or endocytic elimination of it from 
the planarian body. Our studies suggest that NPY-8 is produced by the planarian nervous 
system and its activation through a conserved neuropeptide processing pathway is essen-
tial for reproductive maturity of the planarian.
Results
NPY-8 is required for male and female germ cell maturation
We previously showed that npy-8 is required for proper development and main-
tenance of the testes and the copulatory apparatus in sexual planarians (Collins et al., 
2010). More recently, a DM-domain gene, dmd-1 was shown to be required for specifica-
tion and differentiation of male germ cells in planarians (Chong et al., 2013), suggesting 
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Figure 2.1. Sexually enriched neuropeptide gene npy-8 is required for female germ cell development 
in planarians. (A) Effect of npy-8 knockdown on female germ cell development in sexual planarians. 
Control worms develop complete ovaries with mature oocytes (arrowheads). nanos+ GSCs (orange) and 
gH4+ undifferentiated oogonia (blue) are located on the periphery of the ovary. Worms with reduced npy-
8 expression do not develop mature oocytes. Ovaries are only made of nanos+ GSCs (orange) and gH4+ 
undifferentiated oogonia (blue) in npy-8(RNAi) worms. DAPI (gray) labels nuclei. Scale bars are 100 µm. (B) 
Colorimetric in situ hybridization (ISH) labels npy-8 mRNA in a subset of central and peripheral nervous 
system cells in a sexual planarian (right). No signal is detected in the asexual worm (left). Scale bars are 1 
mm. Modified with permission from Collins et al. 2010. (C) Relative quantities of npy-8 mRNA in hatchlings, 
mature sexuals, and asexual planarian measured by qPCR. Data are normalized to the asexual samples. Error 
bars represent standard error of the mean (SEM) for four individual worms in each condition.
the presence of sex-specific regulatory pathways in the hermaphrodite planarians. This 
prompted us to examine the effect of npy-8 knockdown on the ovaries of the worm. 
Hatchling worms were fed npy-8 or control dsRNA for four weeks, and then fixed and 
analyzed by in situ hybridization (ISH). Upon knockdown of npy-8, no mature oocytes 
were observed in the ovaries, and the only germ cells present in the region were nanos+ 
cells (Figure 2.1A). In planarians, nanos is considered to be specifically expressed in the 
germline stem cells (GSCs), and to a lesser extent, in the eyes (Handberg-Thorsager and 
Saló, 2007; Wang et al., 2007). The results of npy-8 knockdown experiment suggest that 
regular expression of this neuropeptide is essential for the maturation of both male and 
female germ cells.
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NPY-8 is upregulated in sexual planarians compared to asexuals
S. mediterranea exists in two distinct biotypes–sexual and asexual. Sexul planari-
ans produce mature gametes and proliferate sexually via zygote formation, while asexual 
planarians reproduce by transverse fissioning and regeneration of missing body parts. 
Interestingly, asexual planarians still specify a vestigial germline that expresses early germ 
cell markers, such as nanos and germinal histone H4 (gH4), but does not yield mature 
gametes (Wang et al., 2007). These two strains provide a powerful system for comparative 
functional genomic studies focused on the differences between sexual and asexual pla-
narian germ cells and their systemic environment. We have previously shown that npy-8 
mRNA is expressed in a subset of planarian central and peripheral neural cells (Figure 
2.1B) (Collins et al., 2010). To test whether npy-8 is differentially expressed between the 
two planarian strains, we performed quantitative PCR (qPCR) on cDNA prepared from 
asexual planarians, as well as hatchling and mature sexual worms. Our results indicate 
that npy-8 mRNA is expressed at about 50-fold higher levels in both hatchling and mature 
sexual planarians compared to asexuals (n = 4 individual worms) (Figure 2.1C). We used 
the ubiquitously expressed gene Smed-beta-tubulin (bTub) as the internal control to which 
all expression values were normalized.
NPY-8 is expressed in central and peripheral neurons of sexual planarians
We hypothesized that the npy-8 expression pattern represents cell bodies of a sub-
set of neural cells. To reveal the NPY-8 peptide expression we generated specific polyclon-
al antibodies (pAbs) against the variable portion the predicted NPY-8 peptide sequence 
(Figure 2.2A). A 20-amino acid synthetic peptide was used as antigen for generating 
rabbit pAbs (Figure 2.2B). Immunofluorescence using NPY-8 antibodies showed that 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - L N E Y F A I VGR PR F
- - - - - - - - - - - - - - - AMEDD T K S L A E L KN L L SD L N E E Y L I AGR PR F
- - - - - - - - - - - - - - - - - NNNQ L DD PD I QQ Y L QD L NN F YQ F YGR PR F
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Figure 2.2. Generation of specific NPY-8 polyclonal antibodies. (A) Amino acid alignment of the 11 
predicted NPY homologs identified in planarians. Shades of blue indicate the degree of conservation. NPY-8 
portion highlighted by red was chosen as an antigen due to its divergence from other NPYs. (B) Steps involved 
in generation of the NPY-8 antibodies. With the exception of the pre-screening and post-screening steps, the 
procedure was carried out by Covance, Inc. (Princeton, NJ).
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Figure 2.3. Immunofluorescence reveals expression of NPY-8 in the central and peripheral nervous 
systems. (A) Schematic showing major parts of the planarian nervous system and general areas shown in the 
following panels. (B and C) NPY-8 immunofluorescence on ventral and dorsal sides of the planarian. Images 
are maximum intensity projection (MIP) of confocal planes spanning <100 µm of tissue on either side. DAPI 
(blue) labels testes on the dorsal side in C. Scale bars are 1 mm. (D) NPY-8 nerves in cephalic ganglia and brain 
branches. (E) A segment of the ventral nerve cord (VNC) and nearby commissures. (F) Network of NPY-8 
nerves on the planarian dorsal side. Testis lobules (DAPI-rich) can be seen beneath the nerve plexus. (G) Co-
labeling with NPY-8 and synapsin antibodies showing a portion of the VNC with synapse-rich ganglia. (H) 
Cross-section showing NPY-8 cells, with a nerve extension stretching from a ventral ganglion (“vg”) towards 
the dorsal surface. Axonal swellings (varicosities) are indicated by arrowheads on NPY-8 nerve fibers. (I) 
Sagittal section showing NPY-8 nerve crossing the mesenchyme between intestinal branches (“g”). (J) Cross-
section showing NPY-8 axonal extensions near testis lobes (“te”). Testes are made of a layer of large DAPI-rich 
spermatogonial cells on the periphery and more differentiated germ cells towards the middle. Dorsal side is 
on top in H–J. Scale bars are 100 µm in D–J, except in H, where it is 50 µm. Images in B–H are maximum 
intensity projections.
numerous lateral and commissural neurons expressing NPY-8 are part of a ventral nerve 
plexus (Figure 2.3B). NPY-8 is expressed in the cephalic ganglia, and the two longitudinal 
connectives (nerve cords) along the ventral side of the body (Figure 2.3D and E). Another 
group of NPY-8 neurons is present on the dorsal side of the animal (Figure 2.3C). In the 
dorsal plexus, situated just above the testes, fewer neurons with longitudinal extension are 
labeled (compared to the more prominent commissural extensions on the ventral side) 
(Figure 2.3F). Cell bodies of the neurons surround densely packed neuropils and are also 
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scattered throughout the plexuses, similar to the mRNA expression pattern observed by 
ISH (Collins et al., 2010). In separate experiments, we double-labeled with a monoclonal 
antibody (mAb) against Drosophila synapsin that has been used to label synapses in pla-
narians (Cebrià, 2008; Klagges et al., 1996). NPY-8 antibodies colocalize with the synapse 
marker in the connective nodes along the CNS on the ventral side (Figure 2.3G and H).
Immunofluorescence imaging of planarian sections allowed us to study the 
NPY-8-expressing neurons in more detail and scrutinize their interaction with other tis-
sues. This analysis uncovered mesenchymal NPY-8 neurons that go around the intestinal 
branches (Figure 2.3I) and densely packed testis lobes (Figure 2.3J) to, apparently, connect 
the dorsal and ventral nerve plexuses. A prominent feature of the NPY-8 neurons (par-
ticularly in the mesenchyme) is the formation of axonal swellings or varicosities that are 
considered to be neurosecretory terminals capable of neuropeptide release (Brown et al., 
2013; See Clarke, 2015; Morris et al., 1987) (Figure 2.3H–J).
To confirm specificity of the NPY-8 antibodies, we used them for detection of 
NPY-8 peptides in npy-8 knockdown worms. NPY-8 immunofluorescence signal declined 
and eventually disappeared in npy-8(RNAi) worms, pointing to specificity of the NPY-8 
pAbs (Figure 2.4A). We further tested the specificity of NPY-8 pAbs by Western blotting. 
A specific signal for NPY-8 can be detected around the predicted size (3.4 kDa) in neu-
ropeptide extracts of control planarians, but not in those of npy-8(RNAi) worms (Figure 
2.4B). Our neuropeptide extraction procedure does not allow independent detection of 
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fibers is undetectable in npy-8(RNAi) worms. Insets show the morphology of the testes at the same time. (B) 
Western blot showing specific NPY-8 signal in extracts of sexual planarians (control) at around ~3.5 kDa. 
NPY-8 band disappears in neuropeptide extracts from npy-8(RNAi) worms (51 days). Two nonspecific bands 
are used as extraction and loading controls. Image is inverted chemiluminescence signal.
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other known proteins as internal controls, thus, we used non-specific bands in the NPY-8 
WB as loading controls.
Endogenous NPY-8 is a 28-residue C-terminally amidated peptide
We next wanted to determine the endogenous NPY-8 structure. NeuroPred has 
been widely used to predict likely cleavage sites in prohormones and the resulting peptides 
(Southey et al., 2006). Neuropred predicts an N-terminal signal peptide processing site 
and two dibasic cleavage sites resulting in a middle NPY-like peptide with 28 amino acids 
(after putative amidation of the C-terminal glycine) and a monoisotopic protonated mo-
lecular mass (M+H) of 3391.694 Da (Collins et al., 2010) (Figure 2.5A). To confirm these 
predictions, we purified the endogenous NPY-8 and analyzed it by mass spectrometry. We 
used the NPY-8 pAbs to immunoprecipitate endogenous NPY-8 from planarian neuro-
peptides extracts (Figure 2.5B). The purified neuropeptide was immediately analyzed by 
MALDI-TOF and generated a specific peak around 3390 Da, confirming the presence of 
NPY-8 in the sample and its cleavage at the predicted sites (Figure 2.5C). This peak was 
absent in the sample prepared from the asexual worms that express little to no NPY-8, 
indicating specificity of the signal (Figure 2.5D).
Prohormone convertase 2 is required for NPY-8 processing in vivo
Prohormone convertases are a conserved class of subtilisin-like enzymes that are 
responsible for prohormone processing in a eukaryotes from yeast to human (Seidah and 
Chrétien, 1992; Seidah et al., 1990; Smeekens and Steiner, 1990). Typically, these enzymes 
recognize and cleave downstream of arginine/lysine-rich motifs, which are further pro-
cessed by carboxypeptidase-like and peptidylglycine alpha-amidating monooxygenase 
enzymes (Seidah and Chrétien, 1999). Planarians genome encodes five close relatives 
of the prohormone convertase family (Figure 2.6A). The prohormone convertase gene 
Smed-pc2 (pc2) is expressed in planarian nervous system as well as the testes of sexual S. 
mediterranea, and is required for achieving and maintaining sexual maturity (Agata et al., 
1998; Collins et al., 2010). Worms with reduced pc2 expression exhibit severe locomotion 
defects, as well as loss of differentiated germ cells and other reproductive tissues (Collins 
et al., 2010). pc2 is the only planarian prohormone convertase with a reproductive pheno-
type based on our RNAi experiments (Table 2.1). We hypothesized that the reproduction 
phenotype is, at least partly, due to incomplete NPY-8 processing. We have previously 
shown that pc2 is required for processing of a cohort of planarian neuropeptides, but we 
could not detect NPY-8 in our high-throughput mass spectrometry analyses or determine 
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Figure 2.5. Immunoprecipitation and mass spectrometry of endogenous NPY-8 peptide. (A) Predicted 
structure of npy-8 gene product, including a signal peptide, NPY-8, and a C-terminal novel peptide. After 
several hypothetical processing steps, the bioactive NPY-8 has a predicted mass of ~3392 Da. (B) Western 
blot showing NPY-8 signal during the immunoprecipitation (IP) process. The final elution was used for mass 
spectrometry. (C) MALDI-TOF detection of the NPY-8 peptide at the predicted mass in IP sample from 
sexual planarians. Inset shows magnification of the 3380–3420 Da region. (D) MALDI-TOF analysis of IP 
sample from asexual planarians. No NPY-8 can be detected in asexual worms. A non-specific peak around 
3450 Da (asterisk) is present in both C and D. Note the difference in the Y-axis scale between C and D.
whether pc2 is also required for NPY-8 processing (Collins et al., 2010). To address this 
question, we performed anti-NPY-8 Western blot analyses on neuropeptide extracts 
of pc2(RNAi) planarians one or two weeks following the start of RNAi treatment. One 
week after pc2 knockdown, a heavier band (~6 kDa) consistent with unprocessed NPY-8 
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Figure 2.6. Prohormone convertase pc-2 is required for NPY-8 processing. (A) Bayesian inference topology 
of candidate planarian prohormone convertase homologs. Tree is unrooted. Posterior probabilities are 
indicated at every node. Planarian genes are identified by their Unigene identifiers (http://smedgd.neuro.
utah.edu/). (B) Western blot showing changes in NPY-8 processing upon pc2 knockdown. Two biological 
replicates are tested for each condition. Band appearing around ~6 kDa in pc2(RNAi) treatment is consistent 
with unprocessed pro-NPY-8. Nonspecific band at ~20 kDa is used as loading control.
(although without the signal peptide) appears in anti-NPY-8 Western blots, in addition to 
the processed NPY-8 signal (Figure 2.6B). Two weeks after pc2 knockdown, the 3.4 kDa 
processed NPY-8 band is undetectable and all of the NPY-8 peptide appears to be in the 
unprocessed form (Figure 2.6B). This suggests that pc2 function is required for proteolytic 
cleavage of pro-NPY-8 peptide at the predicted dibasic residue site (Figure 2.5A).
A peptidylglycine alpha-hydroxylating monooxygenase is required for planarian 
reproductive development
Many neuropeptides, including NPYs, are activated upon C-terminal amidation 
(Bradbury et al., 1982; Merkler, 1994). Since planarian reproductive maturation is depen-
dent on active NPY-8 peptide, we hypothesized that it would also require NPY-8 amida-
tion. Peptide amidation is a two-step process: first, the C-terminal glycine is hydroxylated 
by a peptidylglycine alpha-hydroxylating monooxygenase (PHM), and then, the interme-
diate is cleaved by a peptidyl-alpha-hydroxyglycine alpha-amidating lyase (PAL) (Eipper 
et al., 1991; Perkins et al., 1990). In vertebrates, PHM and PAL are synthesized as one 
multifunctional enzyme named peptidylglycine alpha-amidating monooxygenase (PAM) 
(Eipper et al., 1993; Ouafik et al., 1992), however, the two activities are sometimes separat-
ed in invertebrates, such as Drosophila (Kolhekar et al., 1997). Among flatworms, a mono-
functional PHM has been identified in the central nervous system of the planarian Duge-
sia japonica (Asada et al., 2005). We identified three PHM domain-containing genes in the 
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S. mediterranea genome (Figure 2.7A). Only one, we named Smed-pam (SMU15006556), 
appears to encode PHM and PAL domains. Another gene, Smed-phm (SMU15001346) 
only encodes the PHM domains, and the third gene, Smed-dbm (SMU15002986), appears 
to be an evolutionarily related dopamine beta-monooxygenase (DBM), based on the pres-
ence of a dopamine beta-monooxygenase N-terminal domain (DOMON) (Southan and 
Kruse, 1989).
To test whether any of the PHM-containing enzymes are required for planari-
an reproductive development we knocked them each down by RNAi. We fed juvenile 
Figure 2.7. Neuropeptide amidating enzyme PHM is required for reproductive maturity. (A) Three PHM-
containing proteins encoded in the planarian genome. PHM enzymes are recognized by the presence of 
copper type II ascorbate-dependent monooxygenase N- and C-terminal domains. DOMON is a dopamine 
monooxygenase domain specific to BDM enzymes. SGL is a SMP-30/Gluconolaconase/LRE-like domain that 
is a hallmark of PAL enzymes. Domain structure is shown to scale. (B) Dorsal side of planarians labeled 
with DAPI. Testes are regressed in phm(RNAi) worms. (C) Ventral side of planarians labeled with DAPI. 
phm(RNAi) worms do not develop a gonopore (“gp”) or store sperm in seminal vesicles (“sv”). Pharynxes (“ph”) 
are marked for comparison. (D) Confocal image of testes labeled with DAPI. All stages of spermatogenesis, 
including round spermatids and elongated sperm can be seen in control worms. Testes in phm(RNAi) worms 
are regressed and only have undifferentiated spermatogonial cells. (E) Confocal image of the ventral head 
region labeled with DAPI. In control worms, fully developed ovaries can be seen at the base of the brain 
(arrowheads). Ovaries are absent in phm(RNAi) planarians. Insets show magnified view of the ovary region. 
(F) Colorimetric ISH showing expression of phm mRNA in the central and peripheral neurons on the ventral 
side of a planarian. (G) Double-FISH experiments showing expression of phm in central (left) and peripheral 
(right) npy-8+ neurons (n=30/30). Expression of phm is much more widespread than that of npy-8. Scale bars 
are 1 mm in B, C, and F, 100 µm in D and E, and 10 µm in G.
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planarians 4 doses of dsRNA corresponding to each of the genes or control dsRNA in 
1-week intervals and waited another week before fixing the worms for fluorescent label-
ing. By the end of the experiment (>1 month) worms in the control treatment developed 
gonopores, as well as testes and ovaries containing mature sperm and oocytes, respectively 
(Figure 2.7B). However, phm(RNAi) worms did not develop visible gonopores, sperm, or 
oocytes (Figure 2.7B). Knockdown of pam or dbm did not produce obvious reproductive 
phenotypes (Table 2.1).
We next wanted to know which tissues express phm in the planarian body. Colori-
metric ISH revealed expression of phm in cells within the central and peripheral nervous 
systems (Figure 2.7C). This expression pattern is consistent with the role of the enzyme in 
neuropeptide amidation, and particularly its involvement in NPY-8 processing. By dou-
ble-fluorescent in situ hybridization (dFISH) we showed that all central and peripheral 
npy-8+ cells coexpress phm, further suggesting that phm is the enzyme responsible for 
NPY-8 amidation (Figure 2.7D).
Protonephridial and intestinal cells internalize fluorophore-labelled NPY-8
Our immunofluorescence results suggest the presence of an extensive network of 
NPY-8-expressing neurons across the planarian body. What happens to NPY-8 after its 
Table 2.1. Genes analyzed by RNAi
Gene Name/RNAi Treatment Symbol Unigene ID ISH Pattern
Producing 
Sperm
Developed 
Gonopore
(control)* - - - 5/5 5/5
prohormone convertase 1-like 1 pc1.1 SMU15000885 n/d** 5/5 5/5
prohormone convertase 1-like 2 pc1.2 SMU15001756 Penis papilla 5/5 5/5
prohormone convertase 2-like pc2 SMU15019018 CNS, PNS, testes 0/5 2/5
prohormone convertase 5-like 1 pc5.1 SMU15036165 Ovaries 5/5 5/5
prohormone convertase 5-like 2 pc5.2 SMU15002657 Testes 5/5 5/5
neuropeptide y superfamily-8 npy-8 SMU15010818 CNS, PNS 1/5 2/5
(control) - - - 5/5
5/5
5/5
5/5
peptidylglycine alpha-hydroxylat-
ing monooxygenase
phm SMU15001346 CNS, PNS 1/5
2/5
2/5
3/5
peptidylglycine alpha-amidating 
monooxygenase
pam SMU15006556 n/d 5/5
5/5
5/5
5/5
dopamine beta-monooxygenase dbm SMU15002986 n/d 5/5
5/5
5/5
5/5
For phm, pam, and dbm results for two independent sets of experiments (n = 5) are shown.
* DsRNA corresponding to pJC53.2 vector insert containing bacterial genes was used as control.
** Based on RNA-seq data, pc1.1 is enriched in intestinal cells (Cluster 2, see the HCC section).
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release into the mesenchyme? To begin to address this question, we decided to identify 
and characterize planarian cell types potentially capable of internalizing NPY-8. To that 
end, we used fluorescently-labeled synthetic NPY-8 peptides to label cells that internal-
ize the peptide in a live-cell suspension. Cells from large sexual worms were incubated 
with fluorescent peptides and FACS-sorted into populations of NPY-8-internalizing 
cells (called “internalizing cells” for simplicity) and control cells (including ~80% of the 
non-internalizing viable cells) (Figure 2.8A). Internalizing cells typically comprised 0.5-
1.5% of total viable cells (Figure 2.8B and C). Confocal imaging shows that the internal-
ized peptide is accumulated within numerous vesicles in the cytoplasm of these cells (Fig-
ure 2.8D). Internalization of NPY-8 is independent of the fluorophore used to label NPY-8 
(Figure 2.8E and F). Cells do not internalize a scrambled version of NPY-8, indicating 
some level of sequence-specificity for the interaction (Figure 2.8E and F). NPY-8-internal-
izing cells exist in both sexual and asexual strains of the planarian and are not sensitive to 
X-ray irradiation, suggesting that they are neither germ cells nor neoblasts (Figure 2.9).
To determine the identity of the internalizing cells, we analyzed their tran-
scriptomes to find tissue-specific markers. We prepared libraries from 20,000-40,000 
FACS-sorted internalizing and control cells. Four independent replicates were sequenced 
for each condition (Internalizing, I-, and Control, C-11, 19, 20, and 26) to yield over 170 
million high-quality reads. RNA-seq reads were mapped to a planarian de novo tran-
scriptome (dd_Smed_v4, Brandl et al., 2016). Analysis of weighted proportions (Baggerly 
et al., 2003) shows that 195 genes are over 10-fold enriched in the internalizing samples 
compared to control (weighted proportions difference > 5E-5, p-value < 0.05) (Table 2.2). 
Focusing on the internalizing-enriched gene set, we noticed that gene expression levels 
vary across the four internalizing replicates, but mostly following two major trends. These 
collective variation trends across replicates could either be due to coordinated regula-
tion of genes enriched in a single cell type, or variation in cell composition, if the sorted 
samples are heterogeneous mixtures of multiple cell types. In the latter case, apparent 
expression levels of markers specific to each cell type would follow a similar pattern across 
technical replicates, which would differ from the pattern followed by markers of the other 
cell type.
To test these possibilities, we performed Hierarchical Correlation Clustering 
(HCC) to group genes based on the covariance of their expression level across technical 
replicates. This method captures similarities in the “shape” of how expression values vary 
within a series of measurements and orders genes in such a way that those with similar 
expression patterns are adjacent (Eisen et al., 1998). We followed this analysis by ISH to 
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Figure 2.8. NPY-8 is specifically internalized by a subset of planarian cells ex vivo. (A) Planarians were 
dissociated into single cell suspensions. Cells were incubated with fluorescent NPY-8 and separated by FACS 
based on their specific ability to interact with the neuropeptide. RNA from these cells is sequenced to identify 
target tissues. (B) Live nucleated cells were separated from cellular debris and fragments using a violet cell-
permeable DNA stain, DyeCycle Violet, and a dead cell stain, SYTOX AADvanced. (C) Fluorescence from the 
Alexa Fluor 488-conjugated peptide (A488-NPY-8) is plotted against that of SYTOX AADvanced. Cells within 
the NPY-8+ gate are considered to have specific interaction with NPY-8, resulting in stronger A488 signal than 
background cells. (D) Confocal imaging of target cells after FACS sorting. Cells have internalized NPY-8 in 
cytoplasmic vesicles. Scale bar is 10 µm. (E) FACS analysis of planarian viable cells incubated with Alexa 
Fluor 488-conjugated NPY-8 and Alexa Fluor 647-conjugated scrambled NPY-8. A specific cell population 
(arrowheads) interacts with A488-NPY-8, but not with A647-Scrambled. (F) Analysis of cells incubated with 
A488-conjugated and A647-conjugated NPY-8 peptides. The same cell population interacts with both NPY-8 
conjugates (arrowheads). Viable cells were gated using a cell-permeable nuclear dye, DyeCycle Violet (DCV), 
and dead cell stain, SYTOX AADvanced. 
reveal reveal expression patterns of the clustered genes. HCC analysis on the 195 inter-
nalizing-enriched genes revealed two major gene clusters (Figure 2.10A). Genes in the 
larger cluster (cluster 1) include numerous ion channels, solute carrier family proteins, as 
well as motor proteins and structural components of cilia (Table 2.2). Colorimetric ISH 
shows these gene are predominantly expressed in the protonephridial cells throughout 
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the body (Figure 2.10B). Genes in the smaller cluster (cluster 2) mainly encode digestive 
enzymes, enzyme inhibitors, secreted proteins, and other proteins involved in processing 
and secretion (Table 2.2). Colorimetric ISH revealed that representatives of this cluster are 
expressed in the intestine, with different degrees of cell type-specificity (Figure 2.10C). In 
situ hybridization experiments confirmed that the variation in gene expression levels was 
Figure 2.9. NPY-8-internalizing cells are not sexual-specific or irradiation sensitive. (A and B) FACS 
plots showing NPY-8-interacting cells from sexual (A) and asexual (B) planarians. In both biotypes, a small 
population of cells internalizes significant amounts of fluorescent NPY-8, enough to separate them from cells 
with background fluorescence. The NPY-8+ population is also shown on a plot against the side scatter area 
property (SSC-A), however, SYTOX AADvanced cell-impermeable nuclear stain seems to provide a more 
linear measure of background fluorescence. (C-F) FACS plots showing NPY-8 internalization by cells from 
control and irradiated (3 days post irradiation, dpi) planarians. Without addition of the fluorescent peptide 
no significant signal can be detected in the green channel (C and E). With peptide incubation, a subset of both 
control and irradiated cells can efficiently interact with NPY-8 (D and F). The percentage of NPY-8-interacting 
cells is even higher in irradiated samples, presumably due to loss of neoblasts. Plots of nuclear stain, DCV, 
against SSC-A reveal the population of planarian cycling cells that seem to incorporate less DCV and are lost 
in irradiated samples (arrowheads).
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Figure 2.10. NPY-8-internalizing cells belong to protonephridial and intestinal tissues. (A) Hierarchical 
Correlation Clustering (HCC) of 195 genes enriched in the target cells reveals two major gene categories 
(1 and 2, bar on the right). Gene expression values are log2-transformed, centered, and normalized, before 
performing HCC and generating the heat map. Only the target replicates were included in HCC. Cluster 1 
(blue) contains 151 genes with highest representation in the target replicate “T-19”. Cluster 2 (pink) contains 
37 genes with highest representation in “T-20”. A small cluster of 7 genes (purple) is closer to cluster 1, but 
shows a significantly different pattern and was not tested. (B) Specific markers of planarian protonephridia 
that are present in cluster 1. Protonephridia ISH images are courtesy of Ryan S. King. (C) Representative 
cluster 2 genes expressed in the intestine. In B and C, closest BLASTp hits are indicated in parentheses and 
scale bars are 1 mm.
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due to differential representation of protonephridial and intestinal cells within the sort-
ed samples. Further, cluster 2 includes a PC1/3, carboxypeptidases, and numerous novel 
peptide hormones among other proteins (Table 2.2), suggesting a role for these intestinal 
cells in endocrine hormone signaling and, possibly, systemic regulation of reproductive 
development. However, a partial RNAi screen of several genes from the intestinal cluster 
did not reveal any obvious reproductive RNAi phenotypes (Table 2.2).
Discussion
Our previous attempts using mass spectrometry to identify NPY-8 in a mixture of 
neuropeptides were not successful (Collins et al., 2010). The NPY-8 antibodies enabled us 
to purify the endogenous peptide at relatively high concentrations, which allowed subse-
quent detailed mass spectrometric analysis. The antibodies were also useful in character-
izing the neurons which produce and release NPY-8. We have focused our studies on the 
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role of NPY-8 in germline development; however, NPY-8 expression in an organism-wide 
network of neural cells that innervate a variety of tissues leaves the possibility open for 
additional physiological functions.
Planarians appear to have two homologs of the vertebrate PC1/3 enzymes, a PC2 
homolog, and two other prohormone convertases that form a monophyletic group with 
vertebrate PC5, 6, and 7 enzymes. Our RNAi experiments show that only pc2 is essential 
for proper reproductive development of planarian and its knockdown produces a pheno-
copy of npy-8(RNAi). Interestingly, the same prohormone convertase is coexpressed with 
npy-8 and is required for proteolytic processing of its product. These data strongly suggest 
that in planarians PC2 is responsible for the cleavage and activation of NPY-8, consis-
tent with in vitro and in vivo observations in mammalian systems (Azaryan et al., 1995; 
Brakch et al., 1997; Paquet et al., 1996). However, in vitro assays involving synthetic or 
purified pro-NPY-8 and recombinant planarian PC2 are required to prove this enzymatic 
activity (Hook et al., 1997).
We also identified three planarian genes encoding PHM domains and showed 
that knockdown of one of them, phm, results in reproductive defects resembling those 
caused by npy-8 RNAi. Similar to pc2, phm is also coexpressed in npy-8 neurons, implying 
involvement of this enzyme in C-terminal amidation of NPY-8. If this hypothesis is true, 
there are two possible scenarios that can cause an NPY-8-related reproductive phenotype. 
Either neural NPY-8 is unstable in its unamidated form and degrades before reaching nec-
essary levels for secretion and downstream action, or the unamidated form accumulates in 
npy-8 neurons, but is unable to bind or activate its cognate receptor. Immunofluorescence 
and Western blot analyses can elucidate NPY-8 levels in phm(RNAi) animals. Further, 
methods such as fourier transform mass spectrometry (FT-MS) possess the necessary 
resolution to distinguish between amidated and unamidated peptides and can be used 
to elucidate the amidation state of NPY-8 in phm(RNAi) planarians. From an evolution-
ary perspective, our results corroborate the notion that, unlike vertebrates, invertebrates 
encode standalone PHMs and bifunctional PAMs on separate loci and the absence of a 
bifunctional PAM in insects such as Drosophila is more of an exception (Atkinson et al., 
2010; Attenborough et al., 2012; Kolhekar et al., 1997; Mair et al., 2004).
We developed a peptide internalization assay to purify a rare population of cells 
that can internalize NPY-8 in live planarian dissociates. Through an implementation of 
covariance clustering methods, we used experimental replicates of ensemble RNA-seq 
data to resolve the cellular composition of this cell population, bypassing the need for 
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single-cell transcriptomics. To the best of our knowledge, covariance clustering of gene 
expression levels have not previously been used for this purpose. Significant levels of vari-
ability in the composition of flow-sorted cell mixtures, relative simplicity of the mixtures, 
and adequate depth of the RNA-seq data contributed to the success of this method. Given 
the right conditions, this method can theoretically be used to resolve heterogenous cell 
populations acquired through any method of tissue isolation, including flow cytometry, 
laser-capture microdissection (LCM), manual dissection, or biopsy.
Our assay demonstrated that intestinal and protonephridial cells are capable of 
internalizing bulk amounts of NPY-8 ex vivo, however, the exact identity of these cells 
is not clear. The planarian intestine is a branched structure that spans their entire body 
and its primary function is food digestion (Bueno et al., 1997; Forsthoefel et al., 2011; 
Garcia-Corrales and Gamo, 1986). A number of studies have revealed potential cellular 
subtypes in the planarian intestine (Baguñà and Romero, 1981; Forsthoefel et al., 2012; 
Zayas et al., 2010). Intestinal phagocytes are perhaps the better described subtype with 
several specific markers. These cells are capable of engulfing food particles, fluorescent 
dextrans, and colloidal magnetic beads, presumably through phagocytosis (Forsthoefel 
et al., 2012). However, none of the markers specific to intestinal phagocytes are enriched 
in cluster 2. Staining with the lectin lens culinaris agglutinin has identified large vacuolar 
cells within the planarian intestine that are putative goblet cells that make up the majority 
of non-phagocyte intestinal cells (Zayas et al., 2010). Also, specific antibodies against a 
planarian rapunzel homolog, RPZ-1, label a subset of large granular intestinal cells with 
similar morphology (Reuter et al., 2015). It is possible that cells within cluster 2 are the 
putative planarian goblet cells. However, primary function of mammalian goblet cells 
is synthesis and secretion of high-molecular-weight proteins and components of mu-
cus (Specian and Oliver, 1991), a functionality that is not represented in cluster 2 genes. 
Further, over-representation of proteases and homologs of Niemann-Pick disease type C 
(NPC) gene suggest roles in digestion, nutrient absorption, and cholesterol transport for 
these cells (Jia et al., 2011). Study of genes identified in this work and other known intes-
tinal markers is necessary to characterize the cellular composition and function of planar-
ian intestinal subtypes. Further studies are required to determine the biological relevance 
of the interaction of intestinal cells with NPY-8 and other neuropeptides.
Protonephridia are the building blocks of the planarian excretory system, responsi-
ble for filtration of extracellular fluids and regulation of bodily osmotic pressure (Hyman, 
1951; Ishii, 1980). The development, regeneration, anatomy, and physiological function of 
planarian protonephridia are better characterized (Rink et al., 2011; Scimone et al., 2011; 
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Thi-Kim Vu et al., 2015). Two essential factors for development and maintenance of pla-
narian protonephridia, Smed-pou2/3 and Smed-egfr-5 are 30 and 40-fold enriched in clus-
ter 1 (Rink et al., 2011; Scimone et al., 2011). Smed-DNAH-b3 and Smed-innexin-10 are 
known flame cell and proximal tubule markers, respectively, and are also highly enriched 
in cluster 1. By contrast, the distal tubule marker Smed-CAVII-1 is not present in cluster 
1, suggesting that flame cells or proximal tubules are the NPY-8-interacting component 
of protonephridia (Rink et al., 2011). Further supporting this hypothesis, planarian solute 
carrier genes enriched in cluster 1, slc15a-2, 5a-2, 20a-1, 22a-3, and 5a-4 are all proximal 
tube markers and the most proximal marker, slc15a-2, is 120-fold enriched (Table 2.2). 
None of the solute carrier genes specific to the distal tube are present in cluster 1 (Thi-Kim 
Vu et al., 2015). In C. elegans, coelomocytes are the closest equivalents of protonephridia 
and are known to act as scavenger cells that take up secreted proteins through bulk endo-
cytosis (Fares and Grant, 2002). It has been shown that secreted YFP-labeled neuropeptide 
NLP-40 accumulates in C. elegans coelomocytes (Wang et al., 2013). Our results suggest 
that interaction with, and potential clearing of, neuropeptides by planarian protonephrid-
ia may be a specific and active process that is conserved across invertebrates.
In summary, we performed in-depth biochemical analysis of NPY-8 and charac-
terized its expression and post-translational modification within the planarian nervous 
system. We then developed a peptide internalization assay to purify planarian cells that 
are able to specifically interact with NPY-8 ex vivo. We coupled FACS and RNA-seq tech-
niques to a covariance clustering method to identify two major NPY-8-interacting cell 
types that are candidates for clearing excess secreted neuropeptides from planarian tis-
sues. Our data strengthen the hypothesis of homology among vertebrate and invertebrate 
NPYs and support future studies on NPY biology in a wide range of animal models.
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CHAPTER 3: 
CHARACTERIZATION OF PLANARIAN GPCR 
COMPLEMENT AND THE NPY-8 RECEPTOR†
Neuropeptides are a major component of animal endocrine systems and the vast 
majority of them perform their function through binding and activating G protein-cou-
pled receptors (GPCRs). In this chapter and the following, we investigated the role of 
GPCRs in dynamic regulation of planarian germline development. By genome-enabled 
receptor mining, we identified 566 putative planarian GPCRs and classified them into 
conserved and phylum-specific subfamilies. We performed a functional screen to identify 
NPYR-1 as the cognate receptor for NPY-8. Similar to NPY-8, knockdown of this recep-
tor results in loss of differentiated germ cells and sexual maturity. NPYR-1 is expressed 
in neuroendocrine cells of the central nervous system and can be activated specifically by 
NPY-8 in cell-based assays. Our studies uncover the complement of planarian GPCRs and 
reveal previously unappreciated roles for these receptors in systemic and local (i.e., niche) 
regulation of germ cell development.
Introduction
G protein-coupled receptors (GPCRs) play critical roles in sexual reproduction, 
guiding germ cell migration, mediating hormonal regulation of gamete development, and 
facilitating the function of accessory reproductive tissues. For example, a complex net-
work of peptidergic neurons in the mammalian hypothalamus controls the release of pitu-
itary gonadotropins that systemically regulate gonadal function. GPCRs mediate various 
†  Data presented in this chapter were originally published in Saberi et al., 2016. I performed all the 
experiments, except the cell-based receptor assays shown in Figure 3.6, which were done by Isabel Beets in 
Dr. Liliane Schoofs’ laboratory, KU Leuven.
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short- and long-range communication events in this hormonal cascade, whether the target 
is another neuron or a gonadal cell. Mutations in several of these GPCRs and their ligands 
are associated with hypogonadotropic hypogonadism and other reproductive disorders 
(Noel and Kaiser, 2011). GPCRs that act as receptors for follicle-stimulating hormone 
(FSH), luteinizing hormone (LH), gonadotropin-releasing hormone (GnRH), kisspeptin, 
prokineticin, and tachykinin play essential roles in systemic regulation of gonadal func-
tion in mammals (Cole et al., 2008; Messager et al., 2005; Millar et al., 2004; Topaloglu 
et al., 2008; Tsutsumi et al., 1992). Despite extensive genetic information and molecular 
studies in mammalian models, much remains to be learned about the role of GPCR sig-
naling in sensing physiological and environmental cues and the evolutionary conservation 
of these mechanisms in regulating reproduction across metazoans.
GPCRs also facilitate germ cell differentiation and maturation cell autonomously. 
CXCR4 in vertebrates and Tre1 in Drosophila enable chemokine-guided migration of pri-
mordial germ cells (PGCs) early in development (Knaut et al., 2003; Kunwar et al., 2003; 
Molyneaux et al., 2003). Other olfactory, adhesion-like, and secretin-like GPCRs and their 
signaling partners are required for the maintenance and proliferation of germline progen-
itors and stem cells as well as gamete morphogenesis (Agnese et al., 2010; Davies et al., 
2004; Goto et al., 2001; Pesce et al., 1996; Schneider and Spradling, 1997; Vaudry et al., 
2000). In many cases, however, GPCR ligands, signaling partners, and functional mecha-
nisms are far from understood.
Platyhelminthes (flatworms) exhibit the remarkable ability to coordinate their 
reproductive development with environmental cues such as body size, nutritional status, 
and season. Upon starvation or severe injury, planarians are capable of reversibly disas-
sembling their reproductive system, presumably to curb metabolic demand or to prepare 
for body-wide tissue remodeling (Newmark and Sánchez Alvarado, 2002). Upon amputa-
tions that entirely remove the reproductive system, the remaining head fragments can re-
specify germ cells and reproductive structures de novo (Morgan, 1901; Wang et al., 2007). 
Further, a number of classic and recent studies suggest that planarian neuroendocrine 
cells systemically influence reproductive development. For example, head amputation, 
which involves removal of the cephalic ganglia, results in regression of the male gonads 
to clusters of PGCs (Fedecka-Bruner, 1967; Ghirardelli, 1965). Owing to its reproductive 
plasticity and the availability of numerous functional genomics tools, we use the planari-
an Schmidtea mediterranea as a model to study regulation of germ cell development and 
reproductive function, focusing here on the GPCR superfamily.
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Flatworm GPCRs have been the focus of very few functional studies that have 
been limited mainly to neurotransmitter response, body patterning through the Wnt/
frizzled pathway, or photoreception by opsins (El-Shehabi et al., 2012; Kobayashi et al., 
2007; Lapan and Reddien, 2012; Taman and Ribeiro, 2011). An earlier genome-wide study 
of flatworm GPCRs is based on an incomplete genome assembly and limited to in silico 
prediction of GPCR genes (Zamanian et al., 2011). While planarian neuropeptides and 
other GPCR ligands have received some attention (Hamdan et al., 2002; Nishimura et al., 
2009; Omar et al., 2007; Taman and Ribeiro, 2009; Zamanian et al., 2012), receptor/ligand 
pairs and their specific physiological function in planarians have not been defined. Our 
recent genome-wide characterization of planarian neuropeptides identified NPY-8, a con-
served neuropeptide Y homolog, that is required for proper development of the planarian 
germline (Collins et al., 2010). Here, we characterized the planarian GPCR complement 
to identify the NPY-8 receptor and other GPCRs involved in regulating germ cell develop-
ment. Our studies suggest that GPCRs within the central nervous system (CNS) and the 
gonads are key components of the signal transduction mechanisms that regulate repro-
ductive development in planarians.
Results
Genome-wide analysis reveals conserved and phylum-specific GPCR families
To explore the role of GPCRs in planarian reproductive biology, we generated a 
comprehensive database of planarian GPCR gene sequences, classes, and expression infor-
mation. A previous database of flatworm GPCRs was based on an early draft of the pla-
narian genome (Zamanian et al., 2011). We found that many GPCR genes are absent from 
this database, while several genes encode proteins that more closely resemble other trans-
membrane protein families. To generate a complete database, we used extensive transcrip-
tomic data to assemble de novo transcriptomes that we mined for putative seven-trans-
membrane receptor sequences (workflow shown in Figure 3.1A; de novo transcriptome 
can be found in (Saberi et al., 2016). Combining these transcriptomic data and sensitive 
pattern-discovery methods, we developed a comprehensive list of 566 GPCRs. We con-
firmed and improved the annotation of 343 previously identified GPCRs and discovered 
223 new ones (GenBank accession numbers for cloned GPCR genes are KX018822–
KX018983; all nucleotide sequences can be found in Saberi et al., 2016). The availability 
of RNA-seq data from specific tissues or experimentally modified planarians revealed a 
great deal of information about GPCR expression in planarians (Table 3.1, Figure 3.1D). 
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Figure 3.1. Discovery and classification of planarian GPCRs. (A) Flowchart outlining identification of 
planarian GPCRs and subsequent follow-up analyses. See Materials and Methods for details. (B) Co-clustering 
of human, planarian, and other invertebrate GPCRs. Connections stronger than 1E-4 were considered for 
clustering. CLANS was run for 20,000 iterations. All planarian GPCRs are included and shown by solid blue 
circles. Human non-olfactory GPCRs (gray four-pointed stars) are used to map the main rhodopsin family 
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A partial in situ hybridization (ISH) screen revealed expression of planarian GPCRs in a 
variety of tissues, including nervous and reproductive systems, intestine, epithelial tissues, 
and presumptive sensory organs (Figure 3.2).
To classify the complement of planarian GPCRs we performed clustering anal-
ysis based on pairwise sequence similarities. This method constructs a graph in which 
nodes represent individual proteins and edges provide attractive forces proportional to 
the sequence similarity between protein pairs. Once the graph is optimized, groups of 
similar proteins aggregate into convex clusters that can be traced computationally (Frickey 
and Lupas, 2004). This method has been successfully used to infer evolutionary related-
ness between highly diverse GPCRs (Jékely, 2013). Sequence clustering analysis indicated 
that the planarian genome encodes receptors belonging to the five conserved metazoan 
GPCR classes: glutamate, rhodopsin, adhesion, frizzled, and secretin (GRAFS; Figure 3.1B 
and 3.3A) (Schiöth and Fredriksson, 2005). The 461-member planarian rhodopsin-like 
family (Figure 3.3A) is expanded beyond the conserved rhodopsin-like receptors, but its 
members still maintain the characteristic (D/E)R(Y/F) motif of rhodopsin-like GPCRs 
(Figure 3.1C). Only 143 of these rhodopsin-like GPCRs are conserved across all meta-
zoans (Rho-C) and are located in the center of the rhodopsin family graph (Figure 3.3A, 
and frizzled, glutamate, secretin, and adhesion receptors (all enclosed in dashed gray lines). Two planarian 
homologs of lung seven transmembrane receptors (LUSTR, GPR107 in humans) are indicated. Human 
and mouse olfactory receptors (pink four-pointed stars) cluster separately, and do not overlap with any 
planarian GPCRs. Similarly, no planarian GPCRs co-cluster with insect odorant receptors or chemoreceptors 
(six-pointed stars), or nematode chemoreceptors (heavy crosses). The only exception is the srw family of 
chemoreceptors that colocalizes with a group of planarian GPCRs. The Rho-L cluster neighbors amine receptors 
within the conserved rhodopsin family, suggesting that its members may retain affinity to small molecule 
ligands. Some members of Srfb have been previously identified as the PROF1 family of GPCRs (Zamanian 
et al., 2011). (C) Neighbour-joining phylogenetic tree showing the hypothetical evolutionary relationship 
between planarian rhodopsin-like GPCRs. Conserved (D/E)R(Y/F) motifs are depicted in sequence logos. 
(D) Relative abundance of planarian GPCRs grouped according to their families or, in case of the rhodopsin 
family, separated by subfamilies. Y-axis shows RPKM values based on a mapping where only the GPCR 
database (and not a transcriptome) was used as the reference. For GPCRs that are differentially expressed 
between sexual and asexual strains, the higher values were used. Bars indicate the median and quartiles. 
GPCRs of the Rho-L subfamily are noticeably less abundant compared to the other groups. Rho-R2 GPCRs are 
the most heterogeneous in terms of relative abundance. Frizzled and secretin GPCRs are on average the most 
abundant groups. (E) Bayesian inference topology of planarian NPY receptors with their closest counterparts 
throughout metazoans. Non-planarian GPCRs were selected only according to highest similarity in HMMER 
search (irrespective of the species of origin). Three types of planarian NPYRs are identified: Type 1 including 
NPYR-1 to 6 and their arthropod and nematode homologs. C. elegans NPR-11 and Drosophila NPFR-1 are in 
this group. Type 2 includes planarian NPYR-8 to 10, in addition to many arthropod homologs. Type 3 includes 
planarian NPYR-11 to 16 and appears to be lophotrochozoan-specific. The snail NPY receptor GRL105 [39] is 
a member of this group. Vertebrate NPYRs form a fourth monophyletic group that appears to be outside of the 
invertebrate clade (although with a lower 0.62 posterior probability). Posterior probabilities are 1.00 at every 
node, except those with a value shown. Commons names or sequence identification numbers (GI) are shown 
for proteins on the tree. Tree is rooted with human and planarian amine receptors.
47
Figure 3.2. Planarian GPCRs are enriched in an assortment of tissues and organ systems. Representative 
colorimetric ISH experiments show GPCRs of different classes enriched in the nervous system, reproductive 
structures, and the intestine. (A) gcr102 is expressed in a cells in the brain (left) and putative sensory organs 
around the edge of the head (right). (B) gcr158 (Rho-R2) is expressed in cells associated with the brain. (C) 
gcr121 (adhesion) is expressed in a few anterolateral cells. (D) gcr106 (metabotropic glutamate receptor) is 
expressed in the brain (left) and the secretory glands around the copulatory apparatus (right). (E) gcr084 
(related to human transmembrane protein 181) is enriched in and around the penis papilla. (F) gcr160 (Rho-L1) 
is expressed in epithelial tissues, including pharynx, seminal vesicles (left), around the head (middle), and the 
vitellaria (right). (G) gcr153 in enriched in the intestine. (H-P) Expression patterns of representative NPYR 
genes. npyr-1, 3, and 7 are expressed in cells in the brain. npyr-2, 5, 6, 8, 9 and 15 are enriched in the testes. 
npyr-4 and 10 did not produce a specific ISH pattern. npyr-11 to 14 and 16 were not tested or did not show 
specific expression. Scale bars are 1 mm where whole animals are shown and 200 µm for insets.
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left). Co-clustering of Rho-C family members and human rhodopsin-like GPCRs revealed 
that planarians have homologs of human alpha- and beta-group GPCRs (e.g. amine and 
peptide receptors, opsins) but not gamma-group (including chemokine receptors) or 
delta-group (including olfactory and purine receptors) or lipid receptors (Figure 3.3B) 
(Schiöth and Fredriksson, 2005).
Other rhodopsin-like families include Rho-L, Rho-R, and Rho-D (arbitrary desig-
nations) that have no known homologs outside of platyhelminthes. The largest and most 
expanded rhodopsin-like family, Srf/w (for “Serpentine receptors of flatworms and srw”), 
contains 199 genes in four subclusters: Srfa, Srfb, and Srfc that appear to be flatworm-spe-
cific, and Srw, members of which aggregate with the srw subfamily of Caenorhabditis 
elegans chemoreceptors (Figure 3.1B). In C. elegans, members of the srw subfamily are 
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the only chemoreceptors with a recognizable sequence similarity to the main rhodopsin 
family (specifically to FMRFamide receptors) (Robertson and Thomas, 2006). While only 
one C. elegans chemoreceptor has been experimentally de-orphanized (Sengupta et al., 
1996), GPCRs of this family are called “chemoreceptors” because a large fraction of them 
are required for chemosensation and/or expressed in chemosensory neurons that respond 
to environmental molecules (Troemel et al., 1995). For simplicity, we call the Srf/w family, 
which includes ophis (see Chapter 4), the planarian chemoreceptor family.
A subset of putative planarian GPCRs (48 rhodopsin-like and 50 others) that did 
not join any convex clusters include homologs of conserved adiponectin receptors, lung 
seven-transmembrane receptors, leucine-rich repeat-containing GPCRs, and receptors 
with no known homologs (not highlighted by a circle in Figure 3.3A). Overall, our analy-
ses reveal that major groups of planarian GPCRs fit within the conserved GRAFS classifi-
cation; however, the rhodopsin-like family in planarians is highly diversified and includes 
multiple invertebrate-specific and potentially flatworm-specific subfamilies.
NPY receptor npyr-1 is required for systemic regulation of germline 
development
We next wanted to know if planarian GPCRs are involved in signalling path-
ways that regulate development and maintenance of the germline. Our previous studies 
have shown that npy-8, an NPY homolog expressed in the planarian nervous system, is 
required for germ cell development and sexual maturity in the worm. RNAi-mediated 
knockdown of npy-8 during post-embryonic development (paradigm in Figure 3.4A) 
blocks differentiation of both male and female germ cells, as well as formation of somatic 
accessory reproductive structures (Figure 3.5A) (Collins et al., 2010). Our identification 
of the planarian GPCR repertoire allowed us to investigate the role of NPY receptors in 
planarian reproductive development. We hypothesized that if NPY-8 acts through a con-
served NPY receptor to promote reproductive development, RNAi knockdown of at least 
one NPY receptor should phenocopy npy-8(RNAi), barring functional redundancy. 
Since NPY receptors are conserved throughout metazoans, to identify planarian 
NPY receptor genes we focused on Rho-C and repeated the clustering analysis only using 
planarian and human rhodopsin-like GPCRs (Figure 3.3B). Our analysis identified 16 
putative planarian NPY receptors that cluster with human NPY receptors (Figure 3.3C). 
Bayesian phylogenetic analyses suggest that planarian NPY receptors exist in three mono-
phyletic groups: one that includes flatworm, arthropod (including Drosophila NPFR-1, 
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(Wen et al., 2005)), and nematode sequences, one that only includes flatworm and arthro-
pod NPYRs, and a third group that appears to be lophotrochozoan-specific (including the 
snail NPY receptor GRL105, (Tensen et al., 1998)) (Figures 3.1E and 3.3D). Colorimetric 
ISH shows that most planarian NPY receptors are expressed in the CNS and the testes 
(Figure 3.2H–P).
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To identify a candidate receptor for NPY-8, we individually knocked down each of 
the NPY receptor genes in planarian hatchlings (Figure 3.4A). Germinal histone H4 (gH4) 
was used as a marker for spermatogonial cells, female germ cells, and neoblasts, and nanos 
was used to label male and female GSCs (Handberg-Thorsager and Saló, 2007; Sato et al., 
2006; Wang et al., 2007). Knockdown of Smed-npyr-1 prevented germ cell differentiation 
and formation of the reproductive system, regardless of the region of the gene targeted 
(Figure 3.4C and D). In control treatments, testes reach maturity and produce sperm 
with compact, elongated chromatin readily visualized by DAPI staining (Figure 3.4E). In 
npyr-1(RNAi) planarians, testes only contain undifferentiated GSCs (nanos+/gH4+) and 
spermatogonia (nanos–/gH4+) (Figure 3.4F). npyr-1 is also essential for female germ cell 
differentiation, as the ovaries in npyr-1(RNAi) worms only include GSCs and undiffer-
entiated oogonia and lack mature oocytes seen in control worms (Figure 3.4G and H). 
Notably, the nanos+ GSC pool was present in all RNAi animals (Figure 3.4E–H) and nanos 
mRNA expression was unaffected as assayed by real-time PCR (Figure 3.5C). We also 
found that npyr-1 is not required for de novo germ cell specification (Figure 3.5B).
Next, we wanted to rule out the possibility that the phenotypes observed after 
npy-8 or npyr-1 RNAi are an indirect consequence of downregulating the other gene. We 
knocked down npy-8 or npyr-1 and found that while the targeted genes are downregulated 
at least 4-fold, expression of the other gene is not affected (Figure 3.5C). Collectively, our 
experiments indicate that npyr-1 knockdown phenotypes closely resemble those of npy-8, 
suggesting that npyr-1 gene product serves as an NPY-8 receptor to systemically regulate 
development of the germ cells into mature gametes.
NPY-8 specifically activates NPYR-1 in vitro
To test whether NPY-8 is able to functionally activate NPYR-1, we performed 
a cell-based receptor-activation assay. We individually expressed three NPY receptors 
encoded by npyr-1, npyr-7, and npyr-8 genes in CHO cells co-expressing the promiscuous 
Gα16 subunit and mitochondrially targeted aequorin (CHO/mtAEQ/G16) (Beets et al., 
2012), which enable sensitive monitoring of intracellular calcium responses to exogenous 
ligands. We then assayed receptor activation after addition of various concentrations of 
synthetic NPY-8, as well as a closely related family member, NPY-1, and scrambled NPY-8 
as controls (Figure 3.6A). NPYR-1 was activated by NPY-8, but not by the control ligands; 
by contrast, cells expressing NPYR-7 or NPYR-8, or transfected with an empty vector 
were not activated (Figure 3.6B and C). Moreover, concentration-response assays showed 
that NPY-8 activates NPYR-1 at nanomolar concentrations, with an EC50 value of 36.7 nM 
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npyr-1). DAPI (gray) labels nuclei. Scale bars are 1 mm in D and 50 µm in E-G.
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(Figure 3.6C). Taken together, our results suggest that NPYR-1 is the cognate receptor for 
NPY-8.
npyr-1 is expressed in neuroendocrine cells in the CNS
To identify tissues potentially targeted by NPY-8 signaling, we characterized the 
expression pattern of npyr-1. Colorimetric ISH revealed that npyr-1 is expressed specif-
ically in a subset of cells in the brain and ventral nerve cords (Figure 3.6D). We did not 
detect npyr-1 expression in the gonads or accessory reproductive tissues, suggesting that 
NPY-8 signaling does not directly target reproductive tissues. S. mediterranea exists in 
two distinct biotypes: hermaphroditic sexuals that reproduce by cross-fertilization, and 
asexuals that reproduce by fission. Asexual planarians specify PGCs but lack differentiated 
germ cells and accessory reproductive tissues (Newmark et al., 2008). Interestingly, asexu-
al planarians express npyr-1 at levels slightly higher than sexuals (Figure 3.5D). Asexuals, 
however, express npy-8 at ~50-fold lower levels, likely not enough to activate the npyr-1 
receptor (Figure 3.5D).
To identify the npyr-1+ cells in the CNS, we examined coexpression of npyr-1 and 
two other nervous system markers: Smed-prohormone convertase 2 (pc2, peptidergic neu-
ral cells, see Chapter 2) (Hook et al., 2008) and Smed-choline acetyltransferase (ChAT, cho-
linergic neurons) (Nishimura et al., 2010). Fluorescent in situ hybridization (FISH) indi-
cates that most npyr-1+ cells are pc2+/ChAT-, suggesting that these cells are not cholinergic 
neurons, but rather neuroendocrine cells that express and release other neuropeptides or 
hormones (Figure 3.6E and F). Moreover, npyr-1+ cells do not express npy-8, inconsistent 
with an autocrine NPY-8 signaling loop (Figure 3.6G). Together, our results suggest that 
NPY-8 targets CNS peptidergic cells through the npyr-1 receptor, resulting in downstream 
signaling that eventually regulates germ cell maturation.
Discussion
We performed a comprehensive bioinformatics analysis to identify and classify 
GPCRs of the planarian S. mediterranea, followed by expression and functional studies to 
characterize roles for these genes in reproductive development. We identified homologs of 
the NPY receptor family and showed that the CNS-expressed npyr-1 is the cognate NPY-8 
receptor and required for differentiation of germ cells into mature gametes in a manner 
similar to that of NPY-8.
55
Novel subfamilies of rhodopsin-like GPCRs have evolved in flatworms
Due to the near-completeness of the genome and abundance of high-quality tran-
scriptomic data, our bioinformatics analysis has likely identified the full complement of 
planarian GPCRs. This collection has increased the number of known planarian GPCRs 
from 343 to 566, and significantly improved the average number of discovered transmem-
brane (TM) domains to over 6.8. Using a combination of similarity-based clustering and 
phylogenetic methods, we were able to classify 516 GPCR genes (91%) into five conserved 
GRAFS families; contrary to a previous report (Zamanian et al., 2011), no significant clus-
ters of non-GRAFS GPCRs were identified in the planarian genome. 
The rhodopsin family of GPCRs is remarkably expanded in planarians. Only 143 
out of 461 of planarian rhodopsin-like GPCRs (Rho-C) cluster with vertebrate counter-
parts and the rest form divergent subfamilies Srf/w, D, L, and R. Srf/w includes repre-
sentatives of the srw family of chemoreceptors. Our data support the hypothesis that the 
invertebrate chemoreceptor family split from the peptide subfamily of receptors sometime 
around the divergence of the protostome ancestor (Krishnan et al., 2014). Other chemo-
receptor-like genes identified in this study (Srfa, Srfb, and Srfc) as well as Rho-L, D, and 
N have no previously reported homologous families, rendering them as potential flat-
worm-specific groups. S. mediterranea is among the most experimentally tractable mem-
bers of the lophotrochozoan superphylum, the biology of which is relatively unexplored 
compared to vertebrates or ecdysozoans. Study of a potentially vast number of function-
alities (e.g. neurotransmission, pheromone signaling, structural roles) facilitated by the 
GPCR subfamilies discovered in this work will enrich our understanding of the diversity 
of strategies utilized in metazoans development and physiology.
Central NPY signaling may have a conserved role in reproductive development
Previous studies in mammals and Drosophila have failed to depict a clear and con-
sistent picture of how NPY and its receptors are involved in reproductive function. NPF 
expression in Drosophila brain is sexually dimorphic and is believed to be centrally in-
volved in mating behaviour (Lee et al., 2006). Also, NPF-deficient flies show a decrease in 
egg laying capacity, but the same effect is not observed in NPFR-1-deficient flies (Wen et 
al., 2005). In mammals, injection of NPY into sex steroid-primed ovariectomized rats in-
duces secretion of LH and GnRH (Sabatino et al., 1990; Urban et al., 1996). Conversely, in 
intact rats, NPY has an inhibitory effect on reproduction by suppressing the pituitary-go-
nadal axis (Pierroz et al., 1996). This effect is exacerbated under conditions of negative 
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energy balance, when the endogenous hypothalamic NPY levels are high, suggesting that 
NPY is responsible for coordinating reproductive function with energy availability (Au-
bert et al., 1998).
NPY receptors are abundant in the CNS of animals, with NPY1R and NPY2R 
being highly enriched in mammalian brains, and NPFR1 expressed in a small number of 
Drosophila brain cells, suggesting a conserved central role for NPY signaling in regulation 
of physiological functions (Brawand et al., 2011; Wen et al., 2005; Yu et al., 2014). Dele-
tion of Y1 and Y4 receptors in mice can, under some conditions, enhance GnRH, LH, or 
sex hormone levels, or mammary gland development, suggesting that NPY receptors may 
act to limit aspects of reproductive development (Pedrazzini et al., 1998; Sainsbury et al., 
2002). In contrast, NPY positively modulates GnRH neuronal output in mammals and 
teleosts (1989; Khorram et al., 1988), implying a systemic pro-germline regulatory func-
tion for NPY. Further complicating the picture, deletion of NPY or its receptors in many 
other studies has lead to no obvious changes in reproductive function, presumably due to 
functional redundancy (among NPY and its paralogs or the NPY receptors) or compensa-
tory mechanisms (Herzog, 2004; Lin et al., 2004).
Our studies have shown that neurally expressed NPY-8 and its receptor within the 
CNS, NPYR-1, are required for proper germline development in planarians. This is consis-
tent with, and may help explain the regression of the reproductive system observed upon 
head amputation in planarians (Fedecka-Bruner, 1967; Ghirardelli, 1965). Our findings 
suggest that NPY signaling plays a conserved role in regulation of reproductive develop-
ment and expression of the npyr-1 receptor in the planarian CNS makes for an even more 
compelling case of evolutionary conservation of NPY signaling function. Furthermore, 
the NPY receptor identified in this work, npyr-1, provides an entry point for cellular and 
molecular studies of NPY receptor signaling and its downstream pathways and binding 
partners.
Overall, our analyses characterize the complement of planarian GPCRs and pave 
the way for studying how this major group of cell surface receptors is involved in devel-
opmental and physiological functions, such as reproduction, regeneration, organogene-
sis, chemosensation, and adaptation. Here, we uncovered a central NPY signaling that is 
systemically required for sexual maturation of planarians. Our findings further support 
the conservation of NPY signaling in flatworms and improve our understanding of how it 
is involved in regulation of metazoan reproductive biology.
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CHAPTER 4: 
CHEMORECEPTOR FAMILY MEMBER OPHIS EXPRESSED 
IN SOMATIC GONADAL CELLS IS REQUIRED FOR GERM 
CELL DIFFERENTIATION‡
The planarian reproductive system can develop or regress based on the presence 
or absence of certain systemic signals. We hypothesized that the ability of the reproduc-
tive system to dynamically respond to external cues is in part facilitated by its expression 
of receptors that are specifically targeted by such signals. Given our genome-wide anno-
tation of planarian GPCRs, we sought to identify those that are expressed in, and may 
be required for development of the reproductive tissues. We found that over 40 GPCRs 
are specifically expressed in the germline or associated somatic reproductive tissues. We 
further characterized a chemoreceptor family member, ophis, that is expressed in somatic 
gonadal cells and required for proper maturation of male and female germ cells–reveal-
ing a new role for these cells in addition to their previously known function in germ cell 
specification. We also used ophis as a specific somatic gonadal cell marker to look into the 
developmental events at early stages of planarian testis development.
Introduction
Development and maintenance of germ cells are regulated by systemic and local 
signals originated from somatic tissues (Markov et al., 2009). These signals are mainly in 
the form of steroid compounds (such as sex hormones) or polypeptide hormones (e.g., 
gonadotropins). Regulation of reproductive function has been extensively studied in 
‡  Data presented in this chapter were originally published in Saberi et al., 2016. I designed and per-
formed all the experiments. Control RNA-seq data in Figure 4.1 were available from experiments done by 
various members of the Newmark Lab. Some RNAi and FISH experiments reported in Figures 4.3-4.6 were 
conducted with assistance from Ayana Jamal.
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mammals, leading to recognition of a neuroendocrine axis that involves neuropeptides 
and gonadotropins secreted from hypothalamus and pituitary and steroid hormones 
produced by somatic cells within gonads. This signaling system coordinates reproduc-
tive maturation with the development of the body and regulates reproductive function 
throughout life. Similarly, invertebrate animals utilize signals from somatic cells in the 
nervous system and gonads to regulate germline development. In ecdysozoan model 
organisms such as Drosophila and Caenorhabditis elegans germ cells are specified through 
maternal determinants, but their maintenance, differentiation, and maturation is regu-
lated by signals from the nervous system and somatic gonadal tissues (for a review see 
Chapter 1).
Planarians have a remarkable capacity to coordinate their germline development 
with somatic signals. We have shown that a central signaling pathway involving the NPY 
homolog npy-8 and its receptor are required for proper development of the reproductive 
system and germ cell differentiation (Collins et al., 2010; Saberi et al., 2016). Another 
recent study has identified a nuclear hormone receptor, Smed-nhr-1, that is expressed in 
accessory reproductive tissues and required for germ cell differentiation, suggesting a role 
for putative steroid hormones in germline regulation (Tharp et al., 2014). Although the 
identity of the signal(s) mediating communication between the CNS and reproductive 
system is unknown, we hypothesized that the latter must have the capacity to receive and 
interpret such cues to regulate reproductive output. Since GPCRs are the largest and most 
versatile group of cell surface receptors, we sought to examine whether any of the GPCRs 
identified in this work are expressed in the planarian reproductive system and involved in 
its development.
The role of somatic gonadal cells in regulation of germ cell development has been 
studied in a variety of vertebrate and invertebrate model organisms. In the mammalian 
testis, somatic Sertoli cells support germ cell differentiation as well as contribute to the 
environment that acts as a niche for male GSCs (Xie, 2008). In Drosophila and C. elegans 
various somatic cell types within testes and ovaries are involved in regulation of mainte-
nance and differentiation of the germline (for a review see Chapter 1). Aside from a num-
ber of model organisms, however, molecular and cellular mechanisms of germ cell devel-
opment and the role of germline-associated somatic tissues in largely unknown across the 
metazoan phyla. In planarians, a DM domain-containing transcription factor, dmd-1, has 
been shown to non-cell autonomously regulate specification of male germ cells (Chong 
et al., 2013). However, dmd-1 is not required for female germ cell specification and main-
tenance, and is expressed in a subset of brain cells in addition to the testes, complicating 
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the efforts to tease apart its functional mechanism. Further, while dmd-1 has been the first 
specific molecular marker for planarian testis niche cells, characterization of planarian 
somatic gonadal cell and their role in development and maintenance of germ cells requires 
identification and study of more molecular markers.
Here we explored the GPCR component of the somatic signaling pathways that 
control germline development in planarians. Using available RNA-seq data, we identified 
46 GPCRs that are enriched in the sexual strain of Schmidtea mediterranea and confirmed 
that a majority of them are enriched in the germline and somatic reproductive tissues. We 
then performed an RNAi screen that showed an orphan chemoreceptor family member, 
ophis, is essential for male and female germ cell differentiation. Finally, specific expression 
of ophis in accessory reproductive tissues and somatic gonadal cells allowed us to visualize 
the early stages of testis development in regenerating planarians.
Results
A subset of planarian GPCRs is enriched in reproductive tissues
Because GPCRs are the largest group of cell-surface receptors, we expected to 
identify additional GPCRs expressed in the reproductive tissues, enabling responses to 
local or systemic cues. To select such candidate genes, we compared transcriptomes of the 
S. mediterranea sexual and asexual biotypes (Figure 4.1A). Genes enriched in the germline 
and reproductive tissues account for the majority of the differences between transcrip-
tomes of the two biotypes (Chong et al., 2011).
Of 566 GPCRs, 46 (~8%) are upregulated in sexual planarians (≥ 4-fold and p-val-
ue < 0.05, Figure 4.1B, Table 3.1). In order to validate expression of candidate GPCRs in 
reproductive tissues we performed ISH on sexually mature planarians. The majority of 
sexually enriched genes (24 of the 27 tested) are expressed in reproductive tissues (Figure 
4.2 and Table 3.1). In testes, with the exception of gcr108, which is expressed in sper-
matocytes and spermatids (Figure 4.1C), all the other examined receptors are enriched in 
spermatogonial cells (e.g. gcr130, Figure 4.1D). Other GPCRs are expressed in accessory 
reproductive organs, such as oviducts and copulatory apparatus (gcr144, Figure 4.1E). 
Only one of the tested GPCRs, gcr157, is enriched in both female and male germ cells 
(Figure 4.1F). These results implicate GPCRs in reception of signals by germ cells and 
their associated somatic tissues.
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The orphan receptor ophis is required for germ cell differentiation and 
reproductive maturity
To determine whether any of the sexually enriched GPCRs are required for re-
productive development, we performed an RNAi screen starting with hatchling planar-
ians (Figure 3.4A). We found that knockdown of a serpentine receptor family (Srf/w) 
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Figure 4.1. A subset of planarian GPCRs is enriched in reproductive tissues. (A) Schematic of the 
reproductive system in the two biotypes of S. mediterranea. Sexual planarians (right) develop a complete 
reproductive system, including mature gonads and accessory reproductive organs. The asexuals (left) contain 
only presumptive gonads with PGCs. (B) Normalized RNA-seq RPKM ratios between sexual and asexual 
planarians plotted against relative abundance of each GPCR gene. Only data points with p-value < 0.05 are 
shown. (C–F) Representative colorimetric ISH experiments used to validate RNA-seq results (n = 24/27 genes 
tested expressed in sexual organs). Sexually enriched genes are expressed in various reproductive tissues, 
including spermatids (C), spermatogonia (D and F), oviducts and female copulatory apparatus (E), and 
ovaries (F). Scale bars are 0.5 mm. Insets in C and D show the area inside the dashed box.
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member we named “ophis” (after the mythological serpent wrapping around the Orphic 
Egg), resulted in animals with immature testes that lack differentiating gH4+ spermatogo-
nial cells, spermatocytes, spermatids, and sperm (Figure 4.3A and B). Ovaries were also 
affected, revealed by the absence of mature oocytes (Figure 4.3C). Seminal vesicles with 
stored sperm were not observed in ophis(RNAi) worms (Figure 4.3A). Despite the loss of 
all differentiating germ cells, all ophis(RNAi) animals retained their pool of nanos+ GSCs 
Figure 4.2. Validation of sexually enriched GPCRs by colorimetric ISH. Colorimetric ISH of representative 
sexually enriched GPCRs. gcr108 (unclustered) is expressed in the inner layer of the testes, suggesting that 
gcr108 expression is enriched in spermatids. Expression of 16 other GPCRs (gcr124–141; members of Rho-L, 
Rho-C, Srf, as well as unclustered; gcr140 was ruled out as a GPCR) are shown in the outer layer of the testes 
where spermatogonial cells are located. gcr143 (unclustered) is expressed in the brain (top) as well as the 
vitellaria (bottom). gcr144 (secretin) is expressed in the oviducts and copulatory apparatus. gcr157 (Sfrb) is 
enriched in the ovaries.
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(Figure 4.3B and C). Therefore, ophis is required for differentiation, but not maintenance, 
of nanos+ GSCs.
ophis is expressed in somatic reproductive tissues, including gonadal niche cells
To determine where ophis is expressed in sexual planarians, we performed whole-
mount ISH. We detected ophis expression in several accessory reproductive tissues, 
including oviducts, tuba, vitellaria, and parts of the copulatory apparatus, as well as in dis-
crete cells in testes (Figure 4.4A). To characterize the cell types in which ophis is expressed 
in the gonads, we performed FISH. In both testes and ovaries, ophis is detected in somatic 
cells (gH4-/nanos-) closely associated with germ cells (Figure 4.4B and C). We previously 
showed that a few somatic cells within each testis lobe express a conserved sex-specif-
ic transcription factor (dmd-1) and lack known germline markers (Chong et al., 2013). 
These dmd-1+ cells are required for specification and maintenance of nanos+ GSCs and are 
thought to contribute to a presumptive germline niche. FISH experiments, revealed coex-
pression of ophis and dmd-1 transcripts in the somatic cells of the testes (Figure 4.4D). The 
nuclei of these cells have an elongated and angular shape, distinct from the round nuclear 
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Figure 4.3. ophis is required for male and female germ cell differentiation. (A) Whole-mount DAPI 
staining of control and ophis(RNAi) worms shows testes (yellow arrows) and stored sperm (inset). Control 
animals (n = 5/5) possess a mature reproductive system, including all differentiated cell types of the testes and 
ovaries, ophis(RNAi) worms (n = 15/15, three independent experiments) lack gonads and mature gametes. 
RNAi treatment (eight dsRNA feedings) started in hatchlings (see Fig 3.4A for the dsRNA feeding paradigm). 
(B and C) Double-FISH labeling GSCs (nanos+, orange) and undifferentiated germ cells (nanos-/gH4+, blue) in 
control and ophis(RNAi) worms. In testes (B), ophis(RNAi) worms contain only nanos+ GSCs and are devoid of 
nanos-/gH4+ spermatogonial cells and DAPI-rich spermatids and sperm. Control worms have fully developed 
testes with spermatids and sperm in the middle of lobules (arrowheads). In ovaries (C), mature oocytes 
are observed in control animals (arrowheads) but not in ophis(RNAi) worms. See Fig 3.4B for a schematic 
representation of the spatial organization of the gonads. DAPI (gray) labels nuclei. Scale bars are 1 mm in A 
and 100 µm in B and C.
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morphology of spermatogonia and spermatids. Furthermore, somatic cells of the testes 
seem to have an expanded cytoplasm, delineated by dmd-1 mRNA expression puncta that 
stretch between germ cells (Figure 4.4D).
A population of dmd-1+ cells also exists in the dorsal mesenchyme (between testis 
lobules) and are potential progenitors of somatic gonadal cells (Chong et al., 2013). By 
FISH, these cells seem to express higher levels of dmd-1 compared to the gonadal somat-
ic cells and do not express ophis (Figure 4.4D). On the ventral side, ophis is abundantly 
expressed in vitellaria, copulatory organs, oviducts, and ovaries (Figure 4.4A and C). 
Ovaries & oviducts
Copulatory apparatus
Vitelline glands
Testes
ovaries &
              oviducts
vitelline
glands
Ventral
A
testes
copulatory
apparatus
Dorsal
D
ophis
1
1
2
2
B
C
Oocytes
Tuba
Sperm
Sperm
nanos
gH4DAPI ophis
dmd-1
ophis
nanos
DAPI
dmd-1
Figure 4.4. ophis is expressed in the somatic gonadal niche. (A) Colorimetric ISH shows expression of ophis 
in somatic reproductive structures. Insets show magnified view of specific tissues indicated by red dashed 
boxes. (B and C) Triple-FISH labeling ophis (magenta), gH4 (blue), and nanos (orange). Within gonads, ophis 
expression is exclusive to somatic cells in the periphery of testis lobules (B) and in presumptive follicle cells of 
the ovaries (C). (D) Triple-FISH labeling ophis (magenta), nanos (orange), and dmd-1 (male somatic gonad 
cells, green) in the testes. ophis and dmd-1 are co-expressed inside testes (magenta arrowheads). dmd-1-only 
cells can be seen outside the testes (green arrowheads). Insets 1 and 2 show magnification of regions indicated 
by numbered yellow dashed boxes. DAPI (gray) labels nuclei in B-D. Scale bars are 1 mm in A, 100 µm in B 
and C, and 50 µm in D.
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In oviducts and ovaries, expression of ophis resembles that of nhr-1, a nuclear hormone 
receptor required for planarian germ cell development (Tharp et al., 2014). ophis+ cells in 
the ovary are also nanos-/gH4-, suggesting that they represent somatic cells of planarian 
ovaries (Figure 4.4C).
ophis knockdown does not affect male GSC specification
Since ophis RNAi did not affect the maintenance of nanos+ GSCs, we tested wheth-
er initial specification of GSCs required somatic ophis expression. We analyzed ophis(R-
NAi) worms through the de novo GSC respecification paradigm shown in Figure 4.5A 
using dmd-1(RNAi) worms as positive controls. While dmd-1(RNAi) worms failed to 
re-specify nanos+ PGCs, respecification appeared normal in control and ophis knockdown 
worms (Figure 4.5B). Our results indicate that although dmd-1 and ophis are both ex-
pressed in the somatic testis cells, their functions differ in that ophis knockdown does not 
affect induction of GSCs or their maintenance.
A subset of dmd-1+ cells turns on ophis and establishes new testes
The appearance of nanos+ GSCs has been the earliest known event marking the 
establishment of new testes in planarians, and previous work on dmd-1 did not directly 
address the role of the somatic gonadal cells in early gonadogenesis. With identification of 
ophis as a second marker for the somatic gonadal cells, we re-examined the developmental 
events leading to formation of a new gonad. With more sensitive ISH techniques (King 
and Newmark, 2013) we find that the majority of sexual planarians possess nanos+ cells at 
hatching. To recapitulate the earliest stages of gonadogenesis (before expression of nanos 
in PGCs) we forced the worms to specify new gonads de novo. To this end, we allowed 
head fragments from wild-type planarians to regenerate new tails and simultaneously 
monitored expression of dmd-1, ophis, and nanos by FISH in the regenerated tissue. We 
observed that nanos+ cells are rarely present one week after amputation, however somatic 
dmd-1+/ophis- and dmd-1+/ophis+ cells appear dorsally (Figure 4.5C). After two weeks of 
regeneration, nanos+ GSCs are present adjacent to the dmd-1+/ophis+ cells on the dorsal 
side (Figure 4.5D). Notably, no nanos+ cells can be found isolated from presumptive so-
matic testis cells, suggesting that direct contact with the somatic niche is required for GSC 
specification and maintenance.
We also followed the progression of gonadogenesis by performing FISH on planar-
ian hatchlings. Early hatchlings (<2 week) resemble 2-week head regenerates in that they 
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Figure 4.5. Somatic dmd-1+/ophis+ cells facilitate testis regeneration and development in planarians. (A) 
Germ cell respecification paradigm used to challenge worms to specify a germline de novo. Specific genes were 
knocked down in worms prior to amputation. After 1 to 2 weeks of posterior regeneration, regenerates were 
fixed and labeled to detect nanos expression. Schematic shows areas imaged in panel B and panels C–F. (B) 
FISH labels nanos+ GSCs in two-week head regenerates of control, dmd-1(RNAi), and ophis(RNAi) planarians. 
Unlike dmd-1, ophis is not required for de novo germ cell specification during regeneration of head fragments. 
Insets show early nanos+ GSCs. (C–F) FISH showing expression of dmd-1, ophis, and nanos during de novo 
gonad regeneration. At one week post-amputation (C), dmd-1+ and dmd1+/ophis+ cells are detected at the 
posterior half of head regenerates. Most worms are devoid of nanos+ germ cells (n = 8/10). At two weeks (D), 
nanos+ cell clusters appear adjacent to dmd-1+/ophis+ cells (n = 10/10 worms). Early hatchlings (<2 weeks old, 
E) express clusters of nanos+ cells near dmd-1+/ophis+ somatic cells. No differentiated germ cells (nanos-) are 
observable within the clusters. In juveniles (F), in addition to all of the previous combinations, testis lobules 
with more differentiated spermatogonial cells (“sg” and arrows, nanos-) appear in the middle of the clusters. 
DAPI (gray) labels nuclei. Scale bars are 500 µm in B and 20 µm in insets and C–F.
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possess dmd-1+ and dmd-1+/ophis+ cells as well as nanos+ GSCs (Figure 4.5E). In juvenile 
planarians (>2 weeks), primitive gonads containing differentiating nanos+ germ cells can 
be observed (Figure 4.5F). In regenerating head fragments, early hatchlings, and juve-
niles, dmd-1+/ophis+ cells can be found outside of presumptive testes (in the mesenchyme, 
Figure 4.5C–F), which is not the case with adult planarians (i.e., ophis expression can only 
be detected in somatic cells within the gonads of adult planarians) (Figure 4.4D). This 
suggests that during homeostasis, dmd-1+ cells either join pre-existing testis lobes before 
expressing ophis, or that de novo testis formation around a dmd-1+/ophis+ cell occurs very 
rapidly. Asexual planarians, which only specify GSCs but are unable to produce gametes, 
possess dmd-1+ gonadal niche cells associated with clusters of nanos+ GSCs (Figure 4.6A). 
Consistent with the RNA-seq data, ophis expression is lower in asexual worms (~5-fold) 
and cannot be detected by FISH (Figure 4.6A and B). These results support the hypoth-
esis that GSCs can give rise to differentiated germ cells only in association with somatic 
gonadal cells that express ophis at detectable levels.
Discussion
Expression of a large number of GPCRs in planarian reproductive system suggests 
that the germline and its associated somatic tissues may respond to a variety of external 
signals. Our RNAi screens only revealed the function a novel chemoreceptor family, ophis, 
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Figure 4.6. Low levels of ophis expression in asexual planarians. (A) FISH labeling nanos (orange), dmd-1 
(green), and ophis (magenta) in whole-mount asexual planarians. Clusters of nanos+ cells are present adjacent 
to dmd-1+ somatic cells on the dorsal side. ophis mRNA is not detectable in somatic cells. Standard imaging 
settings were used. DAPI labels nuclei (gray). Scale bars are 100 µm. (B) qPCR analysis of ophis and dmd-1 
expression in asexual and hatchling and mature sexual planarians. ophis expression is comparable between 
asexuals and hatchling sexuals, but about 4-fold higher in mature sexuals. dmd-1 expression is about 30-fold 
higher in mature sexual worms by qPCR. Expression levels were averaged between four individual animals 
in each treatment and normalized to the expression level of each gene in asexual worms. Error bars represent 
SEM among biological replicates.
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in regulation of germ cell development. Other receptors expressed in the reproductive sys-
tem may be play important roles in planarian germline development, however, functional 
redundancy among them may have prevented the discovery of those role. Sexually en-
riched GPCRs belong to a variety of rhodopsin-like and non-rhodopsin-like families and 
characterization of their function and putative ligands will improve our understanding of 
the mechanisms by which planarian germline responds to its local and systemic environ-
ments.
Diversity of planarian rhodopsin family reveals novel insights into invertebrate 
chemoreception
We show that the large metazoan rhodopsin family has split into multiple diverse 
subfamilies in planarians, of which, only one (Srw) has been reported in other animals. 
Much like in nematodes, planarian GPCRs can potentially act as a versatile toolbox 
enabling them to respond to a wide range of molecules and ligands associated with food, 
predators, or mates (Bargmann, 2006). Chemosensation through sensory neurons can 
coordinate germ cell development with population size and food abundance in C. elegans 
(Dalfó et al., 2012). However, ophis represents an interesting case in which a chemorecep-
tor family member expressed within the somatic niche, rather than specialized sensory 
neurons, regulates germ cell development. No direct homologs of ophis have been identi-
fied in other organisms so far and characterization of its ligand, mechanism of action, and 
downstream pathways will require further studies. Although a majority of invertebrate 
chemoreceptors are as yet orphan, some have been directly linked to odorant or pher-
omone sensation with developmental consequences (Kim et al., 2009; Sengupta et al., 
1996). Whether ophis responds to a pheromone-like molecule, a systemic hormone, or a 
feedback signal from the developing germ cells remains to be discovered. The receptor-ac-
tivation assay used in this work can be used in conjunction with biochemical fractionation 
methods to de-orphanize ophis and other planarian chemoreceptors.
A dual role for planarian somatic gonadal niche cells
GSCs are dependent on interactions with specialized somatic cells to maintain 
their identity and proper function (Xie, 2008). In the mammalian testis, the environ-
ment created in the vicinity of blood vessels by myoid cells, the basement membrane, and 
specialized domains within Sertoli cells provides the niche for male GSCs (Yoshida et al., 
2007). The expansive cytoplasm of Sertoli cells also surrounds germ cells and supports 
their differentiation throughout spermatogenesis (Russell, 1980). However, in Drosophila 
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and C. elegans, there is a division of labor among somatic cells of the gonad, with cap/
hub cells and distal tip cells providing the niche for GSCs and escort/cyst cells and sheath 
cells supporting differentiation of germ cells (Byrd et al., 2014; Lehmann, 2012; Xie and 
Spradling, 2000). In the planarian testes, the dmd-1+/ophis+ cells seem to perform both 
functions simultaneously, much like the Sertoli cells of mammalian testes. It is conceivable 
that somatic ovarian cells are responsible for both the maintenance and differentiation 
of female germ cells as well, however, no genes required for the former function have yet 
been identified in planarians.
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CHAPTER 5: 
CONCLUSIONS AND FUTURE DIRECTIONS
Since Geoffrey Harris’ (1955) famous monograph proposing a neuroendocrine 
control of hypothalamus-pituitary-gonadal axis that regulates reproductive function in 
humans, a lot of attention has been directed to physiological implications of this regula-
tory mechanism and the cellular and developmental biology of the tissues involved. In 
addition to humans and other mammals, homologs of many factors involved in this path-
way have been investigated in a broad range of vertebrate and invertebrate animal models. 
Researchers have tried to compare and contrast mechanisms of soma-germline interaction 
in diverse animal phyla to form a broad understanding of how animals regulate their ger-
mline development and function. Is neuroendocrine control of germline development and 
reproductive function and its underlying mechanisms conserved across animals? What 
can we learn from studying this subject in planarians? In this work, we explored molecu-
lar and cellular mechanisms of planarian germline development by focusing on a central 
neuropeptide Y (NPY) signaling pathway and a novel G protein-coupled receptor (GPCR) 
expressed in the gonads.
The Newmark lab has been interested in extrinsic and intrinsic mechanisms of 
germline development in flatworms. The planarian Schmidtea mediterranea has been the 
focus of several studies that have identified key factors such as nanos and NF-YB that are 
required cell autonomously for germ cell maintenance and self-renewal (Iyer et al., 2016; 
Wang et al., 2007, 2010). However, classic and contemporary experiments suggest that 
planarian germline development is also coordinated with external factors such as develop-
mental stage, nutritional status and, more specifically, cues originating from the nervous 
system (Fedecka-Bruner, 1967; Wang et al., 2007). Also, it is believed that the planarian 
germline is in close association with somatic (gonadal) tissues that regulate germline 
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development through non-autonomous action of genes such as dmd-1 and nhr-1 (Chong 
et al., 2013; Tharp et al., 2014).
Throughout my graduate studies, I was interested in somatic regulation of germ-
line development in planarians and, specifically, the role of neuropeptide hormones and 
cell surface receptors in this regulation. Genome-wide analyses of planarian neuropep-
tides and the discovery of NPY-8 and its significance for planarian sexual maturation pro-
vided a good entry point for studying the role of systemic hormone signaling in regulation 
of planarian germline development. My initial work (presented in Chapter 2) concerned 
characterization of NPY-8 peptide expression and post-translational modifications. I then 
focused on discovery and classification of planarian GPCRs with the goal of identifying 
the NPY-8 receptor and other receptors involved in regulation of germ cells (Chapters 3 
and 4). My results suggest that NPY-8 structure, expression, and a number of enzymes 
implicated in its processing are conserved in planarians. I also revealed an intra-CNS 
signaling pathway involving NPY-8 and its receptor that systemically controls germline 
development in sexual planarians. Finally, I showed that the orphan chemoreceptor family 
member ophis is expressed in gonadal niche cells and is essential for germ cell differen-
tiation, further improving our understanding of the relationship between germline and 
somatic gonad tissue in planarians.
Biochemistry of planarian NPY-8
NPY is a conserved neuropeptide expressed in central and peripheral nervous 
systems of many vertebrate and invertebrate animals. Physiological experiments have 
established a conserved role for NPY in feeding behavior and energy homeostasis among 
diverse phyla of animals, but its function in regulation of metazoan germline development 
and reproduction is far from understood. Previously, neuropeptide Y homolog npy-8 
was shown to be required for planarian germline development and its mRNA expression 
was described (Collins et al., 2010), however, its structure and expression at the protein 
level remained unknown. To address this issue, I developed specific antibodies against 
an antigen derived from npy-8 gene product and optimized their use in immunofluores-
cence (IF), immunoprecipitation (IP), and Western blotting (WB) methods. IF experi-
ments showed that NPY-8 is widely expressed in planarian cephalic ganglia, longitudinal 
nerve cords, dorsal and ventral nerve plexuses, and peripheral neurons with extensions 
that innervate most mesenchymal tissues. Given the specificity of NPY-8 antibodies, they 
will potentially be useful in other immunolabeling techniques such as immuno-elec-
tron microscopy (immuno-EM). IP experiments using these antibodies allowed partial 
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purification of the endogenous NPY-8 from planarian neuropeptide extracts and subse-
quent analysis by mass spectrometry (MS)–a feat that had not been achieved through bulk 
MS analysis of planarian neuropeptides (Collins et al., 2010). These experiments revealed 
that the endogenous NPY-8 is a 28-amino acid amidated peptide, consistent with our pre-
dicted neuropeptide processing mechanism (Collins et al., 2010). Also, WB experiments 
using these antibodies provided a straightforward way for quantitative measurement of 
NPY-8 peptide levels and the state of its processing in vivo. Using this method, we showed 
that pc2 is required for proteolytic cleavage of the NPY-8 precursor, suggesting that the re-
productive phenotype of pc2 could be due to incomplete NPY-8 processing. These results 
can be bolstered by MS analysis of the incomplete NPY-8 processing products resulting 
for pc2 RNAi.
Next, to further explore the NPY-8 processing pathway, I focused on a class of en-
zymes required for neuropeptide amidation: peptidylglycine alpha-hydroxylating mono-
oxygenase (PHM). I showed that the planarian genome encodes three PHM-containing 
genes but only one of them, which I designated as Smed-phm, is required for reproductive 
maturity, similar to npy-8. While this phenocopy implies that phm is required for ami-
dation, and thus, activation of NPY-8, it does not reveal the mechanism involved in the 
process. Is NPY-8 unstable without C-terminal amidation, such that it degrades before 
reaching necessary levels to carry out its function? Is unamidated NPY-8 able to bind and/
or activate its receptor? Western blot analysis of neuropeptide extracts from phm(RNAi) 
planarians will address the former question. Further, MS methods, specifically those with 
ultrahigh mass resolution such as Fourier transform mass spectrometry (FT-MS) could 
resolve the difference between amidated and unamidated NPY-8. Several other enzymes 
are thought to be involved in neuropeptide processing in animals, e.g., carboxypeptidases 
that act in tandem with prohormone convertases to remove basic C-terminal residues, or 
peptidyl-alpha-hydroxyglycine alpha-amidating lyases (PALs) and cytochrome b561 that 
are involved in C-terminal amidation. Homologs of PALs and cytochrome b561 are found 
in the planarian nervous system (Asada et al., 2002, 2005) but their role in neuropeptide 
processing or other aspects of planarian physiology is unknown.
Interaction of protonephridial and intestinal cells with NPY-8
Characterization of the bioactive NPY-8 structure allowed us to synthesize large 
amounts of the peptide for ex vivo internalization (Chapter 2) and receptor activation 
assays (Chapter 3). NPY-8 internalization assays were originally designed with the goal of 
identifying NPY-8 target cells. By FACS, we were able to purify a subset of protonephridial 
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and intestinal cells that accumulated significant amounts of NPY-8. NPY-8-interacting 
cells do not express significant levels of npyr-1, which we identified as the cognate NPY-8 
receptor (Chapter 3). We presume that receptor-activated internalization of fluorescent 
NPY-8 (even if possible through interaction with NPYR-1) was not enough for specific 
labeling of NPY-8 target cells in the CNS. Thus, NPY-8 internalization by intestinal and 
protonephridial cells happened either via interaction with other unknown receptors or 
by “bulk” endocytosis. Neither of these two cells types has previously been implicated in 
regulation of germline development, and our partial RNAi screen of specific intestinal 
markers did not reveal any reproductive phenotypes either.
These results are inconsistent with a role for intestinal and protonephridial cells 
as downstream signaling centers that regulate germline development by responding to 
NPY-8. However, they may be significant from other perspectives. At the very least, inter-
nalization of fluorescent NPY-8 (and potentially other neuropeptides) can be utilized as 
a method for purification of cell types that would help characterize the cellular structure 
of planarian excretory and digestive systems. Moreover, neuropeptide internalization by 
these two cell types may be a conserved mechanism by which animals clear the excess 
secreted neuropeptides from their extracellular fluid. Future studies could explore this 
possibility by recapitulating this experiment with a wider range of neuropeptides, and by 
injection of fluorescent neuropeptides into the mesenchyme (in vivo). It would also be in-
teresting to know whether ablation of the protonephridial system or blocking the function 
of the cluster 2 intestinal subtype would result in accumulation of neuropeptides in the 
planarian body–which can, for example, be tested by WB in the case of NPY-8.
Planarian GPCRs and the NPY-8 receptor
In our quest to find the NPY-8 receptor, we identified and classified the comple-
ment of planarian GPCRs (Chapter 3). Our recursive sequence- and pattern-based search-
es resulted in a near-complete set of 566 putative planarian GPCRs, the majority of which 
belong to one of the five conserved metazoan GPCRs families. These GPCRs are likely 
expressed in a range of different planarian tissues and involved in a variety of physiologi-
cal functions. In this work, we revealed the expression pattern of nearly a hundred GPCRs 
genes, and explored the potential function of a subset of those, with regards to regulation 
of reproductive development. Planarian GPCRs and their roles in different aspects of 
flatworm biology, such as development, regeneration, and behavior, remain largely un-
known and can be the focus of many future studies. Further, our comprehensive analysis 
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of conserved and phylum-specific planarian GPCR families can guide efforts to reveal the 
evolutionary history of metazoan GPCRs.
Classification of planarian GPCRs and the subsequent phylogenetic analyses to 
identify potential NPY receptors were performed with the primary goal of finding the 
NPY-8 receptor. We demonstrated that only npyr-1 is required for reproductive devel-
opment–similar to npy-8. We also showed that synthetic NPY-8 can activate CHO cells 
transfected with plasmids encoding npyr-1, suggesting that the two molecules constitute 
a ligand/receptor pair. Interestingly, npyr-1 is specifically expressed in a subset of cells 
within the CNS that co-express pc2–suggestive of a downstream neuroendocrine role for 
these cells. Given the fact that central NPY-8 signaling regulates germ cell development 
in planarian gonads, it could be hypothesized that long-range signaling molecules (e.g., 
hormones) are produced in response to NPY-8 binding by the npyr-1+ cells of the brain 
that provide the necessary developmental cues to the gonads. What is the identity of these 
secondary signals? Do they directly target germ cells, somatic reproductive tissues, or yet 
other types of neurons? How is their production and release regulated in the brain?
To approach these questions, a combination of transcriptomic, proteomic, and 
metabolomic methods could be applied. For example, changes in gene expression can be 
assessed by comparing transcriptomes of control (sexual), npy-8(RNAi), and npyr-1(RNAi) 
worms by RNA-seq. Genes that are down-regulated upon knockdown of both npy-8 and 
npyr-1 are suitable candidates to tease apart transcriptional regulatory pathways down-
stream of NPY-8 signaling. Conversely, genes that are down-regulated in only one of the 
two knockdowns can provide clues about other potential functions of npy-8 and npyr-1, 
should either of them act in a pleiotropic manner. To increase the specificity of these 
experiments, dissected head fragment (rather than whole animals) can be analyzed. As 
shown in Chapters 2 and 3, asexual worms express npyr-1, but not npy-8, at comparable 
levels to sexuals. Head tissues from asexual worms can be analyzed, in parallel, to validate 
the results of npy-8(RNAi) at a genome-wide level, and to shed light on the differences 
between “sexual and asexual brains”.
Similarly, proteins and metabolites produced upon activation of NPY-8 target cells 
can be analyzed through a combination of electrophoresis, chromatography, and mass 
spectrometry methods. Identifying genes, proteins, and small molecules downstream of 
NPY-8 signaling, and their potential roles in germline development, could improve our 
understanding of systemic control of reproductive function in planarians.
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Somatic gonadal cells and the function of ophis
While a lot has been learned about planarian germ cell biology in the past, not 
much is known about how somatic cells of gonads interact with germ cells and what roles 
they play in germline development. Somatic cells of planarian gonads have been described 
at ultrastructural and cytochemical levels (Farnesi et al., 1977; Franquinet and Lender, 
1973; Gremigni and Nigro, 1983). Only recently, genes with specific expression in these 
cells and their roles in germline development have been discovered (Chong et al., 2013; 
Tharp et al., 2014). Expression of ophis in somatic cells of male and female gonads adds 
to the collection of markers that can be used for further characterization of these cells. In 
addition to FISH experiments, which only label ophis mRNA, immunofluorescence using 
potential antibodies raised against the ophis gene product will be tremendously helpful in 
visualization of somatic gonadal cells and their interaction with germ cells. Given the fact 
that ophis is a putative cell surface receptor, such antibodies would be particularly useful 
as they could also be used for FACS purification and subsequent RNA-seq analysis of this 
poorly understood cell type.
Expression of ophis in testes and ovaries and its role in germ cell differentiation is 
intriguing, but much remains to be understood about the mechanism of its action. Being 
a member of the Srf/w family of chemoreceptors, it is conceivable that the ophis recep-
tor responds to small molecules originating from tissues outside of the gonad. What are 
these molecules? Which tissues produce and release them? We have shown that cell-based 
receptor-activation assays can be used to validate potential ligands of planarian GPCRs. 
Such assays can be used to test whether fractions of planarian tissue extracts can activate 
the ophis receptor in vitro. These fractions can be obtained by chemical fractionation, 
filtration, or liquid chromatography, and the process can be repeated until a relatively pure 
fraction capable of receptor activation (and suitable for MS analysis) is obtained. Fol-
lowing the identification of the potential ophis ligand, further studies can dissect out the 
expression of the ligand and its functional mechanism.
Planarian GPCR research can guide similar studies in parasitic flatworms
Parasitic members of the phylum Platyhelminthes are equally impressive with 
regards to their reproductive development, managing to maintain reproductive potential 
throughout the many stages of their life cycle and reaching sexual maturity at the ap-
propriate time and place within the suitable host (Collins et al., 2013; Kunz and Werner, 
2001). Furthermore, parasitic flatworms, such as Schistosoma mansoni, infect over 200 
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million people and cause major health concerns in developing countries (Colley et al., 
2014). Currently, praziquantel is the only therapeutic agent available for schistosomiasis 
treatment (Ross et al., 2002), and the threat of developing resistance in patients warrants 
a systematic search for novel therapeutic targets. Characterization of the planarian GPCR 
complement will guide similar studies in related parasitic flatworms such as S. mansoni in 
which flatworm-specific receptor families could constitute potential drug targets (Zama-
nian et al., 2011).
Research presented in this thesis illustrates the value of planarians for enrich-
ing our understanding of germ cells and their interaction with the soma. A number of 
well-established functional genomic tools, such as in situ hybridization, RNA-seq, and 
RNA interference, have been developed in planarians and used extensively in this work. 
We sought to complement these approaches with mass spectrometric analyses, cell-based 
receptor-activation assays, peptide-internalization experiments, and novel RNA-seq data 
analysis methods, to further elucidate the function of genes and cell types we focused on. 
Planarian research can inform our knowledge of how the nervous system and gonadal 
tissues are parts of a complex network of somatic interactions that maintains the germline 
and regulates its function. What is learned in planarians will not only give us insight into 
the evolution of soma-germline interaction in animals, but also guide similar studies in 
vertebrates, including mammals.
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CHAPTER 6: 
MATERIALS AND METHODS
Planarian husbandry
Sexual and asexual S. mediterranea were maintained at 18°C in 0.75X Montjuïc 
salts (Cebrià and Newmark, 2005) or 0.5 g/L Instant Ocean Sea Salts (Spectrum Brands), 
respectively. Animals were starved at least one week prior to use. For all experiments with 
sexual S. mediterranea, worms ≥ 8 mm length were used, unless otherwise specified.
Generation of polyclonal NPY-8 antibodies
We used NeuroPred (Southey et al., 2006) to predict possible cleavage sites within 
the amino acid sequence of the NPY-8 proneuropeptide and deduce the NPY-like pep-
tide sequence (Figure 2.2A). The more variable N-terminal portion of this sequence (20 
amino acids) was used to immunize rabbits. A cysteine was added to the N-terminus of 
the peptide, and the C-terminus was amidated to improve stability. The peptide was then 
conjugated to keyhole limpet hemocyanin (KLH) and used for 3 injections (0.5 µg each) 
during a 77-day immunization protocol. The rabbits were pre-selected from a pool of six 
animals based on the lowest background immunolabeling by preimmune sera against 
planarian tissues. At the end of the immunization period, the serum with highest specific 
signal-to-noise ratio was selected for purification against the original peptide antigen and 
future experiments.
Immunofluorescence and microscopy
For immunofluorescence, animals were starved for at least 4 days, then killed in 2 
N HCl for 2 minutes (sensitive) and fixed in 4% formaldehyde in PBS for 2 hours in cold. 
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Specimens were then bleached overnight in 6% aqueous hydrogen peroxide, rinsed in 
PBS, and blocked in 0.6% BSA, 1% fish gelatin, and 0.03% Triton X-100 in PBS. For im-
munofluorescence on sections, after fixation in formaldehyde, samples were cryoprotected 
in 15% and then 30% sucrose in PBSTx and cryosectioned in tissue freezing media. After 
blocking for 1 hour at room temperature, samples were incubated with purified polyclon-
al antibodies at 1:2000 dilution overnight at 4ºC. A goat-anti-rabbit antibody conjugated 
to Alexa Fluor 568 or horseradish peroxidase was used at 1:1000 dilution for detection. 
HRP-conjugated secondary antibody incubation was followed by a homebrew tyramide 
signal amplification (TSA) detection. Antibody incubation times were 30 minutes when 
tissue sections were used. Immunofluorescent samples were imaged on a Zeiss LSM 710 
confocal microscope.
Neuropeptide extraction
For increased specificity, we extracted planarian neuropeptides using a modifi-
cation of published methods (Sturm et al., 2010) prior to detection by Western blots or 
immunoprecipitation. To inactivate endogenous proteases, worms were killed in 80ºC 
planarian water for 1 minute and flash frozen on dry ice. Frozen specimens were then 
transferred to a chilled glass-teflon or glass-glass (small clearance) homogenizer and 
homogenized by 20 strokes of the pestle in acidified methanol (mix of methanol, acetic 
acid, and water at 90:9:1; 1 mL for every 5 worms). To increase the extraction efficiency, 
the homogenate was then stirred at 4ºC for an hour. After centrifugation at >14,000 g for 
20 minutes to pellet insoluble materials, the supernatant (containing neuropeptides) was 
frozen in liquid nitrogen and vacuum-dried overnight.
Western blot analysis
Vacuum-dried neuropeptide extract was solubilized in 100 µL of 1X lithium do-
decyl sulfate (LDS) sample buffer containing 100 mM dithiothreitol (DTT) by incubation 
at 70-80ºC for 10 minutes. Sample buffer was then cleared by centrifugation at >14,000 
g for 5 minutes and 10 µL of the supernatant was loaded on a NuPAGE Novex 12% Bis-
Tris gel (Invitrogen, Cat no. NP0341). Electrophoresis was performed in 2-ethanesulfonic 
(MES) running buffer at 80 V for 10 minutes followed by 160 V for 40 minutes.
After electrophoresis, the gel was submitted to semidry transfer in 2X NuPAGE 
Transfer Buffer (Invitrogen, Cat no. NP0006) containing 20% methanol onto small-pore 
(0.2 µm) Immobilon-PSQ (prewet in methanol) membrane at 20 V for 40 minutes. After 
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transfer, the membrane was briefly rinsed in water and air-dried for 2 hours and incubat-
ed in phosphate buffer saline containing 0.05% Tween-20 (PBSTw), 5% BSA, 1% casein, 
and a 1:10000 dilution of affinity-purified anti-NPY-8 antibodies for 4 hours at 4ºC. This 
was followed by three 10-minute washes in PBSTw at room temperature and incubation 
with a 1:10,000 dilution of HRP-conjugated anti-rabbit antibodies (Jackson Laboratories) 
in the same antibody incubation buffer for 2 hours at 4ºC. After three final 10-minute 
washes in PBSTw, the membrane was treated with ECL Western Blot Detection Reagent 
(Amersham) according to manufacturer’s instructions and imaged with a FluorChem Q 
system (Alpha Infotech).
NPY-8 immunoprecipitation
Dried neuropeptide extract was solubilized in IP buffer (PBS pH 7.4 containing 1 
mM EDTA and 1X protease inhibitors; detergents were avoided since they interfere with 
mass spectrometric analysis) by vortexing. Soluble peptides were incubated with 1 µg/mL 
purified primary antibody (1:1000 dilution) at 4ºC overnight. The mixture was centrifuged 
at 14,000 rcf for 20 minutes to pellet insoluble materials. Protein A-conjugated beads were 
rinsed three times in IP buffer and then used to pull down immunocomplexes by incuba-
tion for 1 hour in the cold room as per manufacturer instructions. Beads were rinsed in IP 
buffer three times before incubation with LDS sample buffer for electrophoresis. For mass 
spectrometry, two additional water rinse steps were added at the end. NPY-8 was finally 
eluted in mixture of acetonitrile:water:trifluoroacetic acid (50:47.5:2.5) for 10 minutes and 
vacuum-dried.
RNAi gene knockdown
Knockdowns were generated by feeding in vitro transcribed dsRNA, as previously 
described (Collins et al., 2010), and using dsRNA matching the ccdB and camR-contain-
ing insert of pJC53.2 as a control. Worms were fed with 5 μg of dsRNA combined with 45 
μL of a 3:1 calf liver:water mixture. For the innate development paradigm, cut and regen-
erated worms smaller than 8 mm were fed dsRNA 8 times, every 6 days (Figure 3.4A). For 
the respecification paradigm, mature worms were fed 2 doses of dsRNA, cut anterior to 
the ovaries, and the head fragments were allowed to regenerate for 2 weeks, unless other-
wise specified (Figure 4.5A).
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Colorimetric in situ hybridization
Whole-mount ISH was performed with a formaldehyde-based fixation procedure 
as previously described (King and Newmark, 2013). The protocol was optimized for larger 
sexual planarians: formaldehyde fixation was increased to 30 min, proteinase K treatment 
was increased to 30 min, and post-fixation was increased to 20 min. Colorimetric and 
FISH samples were imaged on an Axio Zoom.V16 (Carl Zeiss, Germany), respectively. 
ISH probes were synthesized according to the methods previously described (King and 
Newmark, 2013). Single-stranded RNA probes were labeled with digoxigenin (DIG). 
DIG-labelled probes were detected by AP-conjugated antibodies and developed with ni-
tro-blue tetrazolium (NBT) and 5-bromo-4-chloro-3’-indolyl phosphate (BCIP).
Fluorescent peptide-activated cell sorting
To achieve maximum viability and transcriptome preservation, large sexual worms 
were finely minced and dissociated in 1.2X CMF (Reddien et al., 2005) containing 0.5% 
bovine serum albumin, 1 U/mL neutral protease (dispase), and 10 µg/mL DNase I. Tissues 
were disrupted by occasional pipetting using a flamed glass pipet. Aliquots of the super-
natant were removed and fresh dissociation buffer was added every 5 minutes until most 
of the tissue fragments were dissociated. The combined supernatant was filtered through 
a 100 µm nylon mesh and cells were spun down at 200 rcf for 4 minutes twice. Cell pellet 
was resuspended in 1.2X CMF containing BSA and DNase I. Mechanical tissue disrup-
tion, centrifugation, and filtration steps were done within 40 minutes to preserve cell 
viability and function.
DyeCycle Violet (DCV) was diluted 1:20 in water before use. Exactly 20 µL of di-
luted DCV (1:2000) and 4 µL conjugated peptide (200 µM) were added to 4 mL of dissoci-
ated cells and incubated in the dark for 15 min. Cells were spun down and incubated in 2 
mL CMF containing DCV (1:2000) and SYTOX AADvanced (1:2000) for another 30 min. 
Cells were finally filtered through a 30 µm nylon mesh without any additional rinsing. 
Labelled cells were analyzed by Becton Dickinson LSR II Flow Cytometer or sorted by BD 
FACSAria II. For sorting, a 85 µm nozzle was used to reach a balance between cell viabili-
ty and small sorted liquid volume.
Synthetic bioactive NPY-8 conjugated to Alexa Fluor 488 was used to detect 
NPY-8-interacting cells via blue laser induction (530/30 nm filter). A secondary channel 
at 695/40 nm was simultaneously used to detect autofluorescence, as well as the SYTOX 
AADvanced dead cell stain. To test specificity, scrambled NPY-8 conjugated to Alexa 
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Fluor 488 and NPY-8 conjugated to Alexa Fluor 647 were used. All peptides were synthe-
sized by New England Peptide (Gardner, MA) and were >90% pure according to manufac-
turer tests. Cells were sorted directly into RLT lysis buffer supplemented with 2-mercap-
toethanol and processed for RNA extraction by QIAGEN RNeasy Micro Kit immediately.
RNA sequencing and analysis
Total RNA (40-100 ng from each sample) was analyzed on an Agilent Bioanalyzer 
for integrity. Illumina TruSeq RNA Prep kit was used for mRNA purification and cDNA 
library synthesis. Libraries were normalized to 10 µg/µL and their quality was checked 
on Bioanalyzer. Libraries were then sequenced on an Illumina HiSeq platform. Mapping 
and analysis of the reads were performed using CLC Genomics Workbench 7. Weighted 
fold-changes, proportions differences, and p-values were calculated using Baggerley’s test 
(Baggerly et al., 2003).
Hierarchical Correlation Clustering (HCC)
Cluster 3.0 (Michael Eisen, Stanford University) and Java TreeView (Alok Sal-
danha, Stanford University) packages were used for HCC and visualization of the results. 
Genes enriched in sorted internalizing cells were selected based on >10-fold enrichment 
in test over control (~80% of non-NPY-8-interacting viable) cells and a minimum propor-
tions difference of 5E-5. These criteria automatically resulted in all p-values being smaller 
than 0.05. After removing alternative splice forms, 195 enriched genes remained for HCC 
analysis. RPKM values corresponding to genes in internalizing replicates (I-11, I-19, I-20, 
and I-26) were loaded on Cluster 3.0. Values for each gene were then log2 transformed, 
centered around the mean (of the four replicates), and normalized, successively. These 
values were then used for average linkage hierarchical clustering with Pearson correlation 
as the distance metric.
Discovery of planarian GPCRs
To maximize coverage of the sexual and asexual strains of the planarian, we de-
veloped two strain-specific de novo transcriptomes which we then combined and used 
for receptor mining (FASTA file in Saberi et. al, 2016). For some gene curations, we also 
used a publicly available assembly that was generated through a different methodology 
(PlanMine v2.0beta, http://planmine.mpi-cbg.de/planmine/). Transcriptomes were mined 
using tBLASTx (BLOSUM62) and HMMer (Eddy, 2011) to identify potential receptor 
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sequences. Conserved GPCRs from other organisms and previously published GPCR da-
tabases (Zamanian et al., 2011) were used as a seed dataset to discover planarian GPCRs. 
Where possible, we expanded and curated the transcripts to reach the ends of the open 
reading frames (ORFs). ORFs were marked ‘5’’ if we found a stop codon closely followed 
by an AUG start codon at the 5’-end of the transcript. ORFs were marked ‘3’’ if we found 
a stop codon at the 3’-end. If both of these conditions were met, the entry was marked 
‘5’–3’’. A pool of potential receptor sequences was then filtered to exclude non-GPCR se-
quences, namely, those that showed significant similarity to other types of transmembrane 
proteins, such as ion channels or solute carrier proteins (E-value < 1E-10 for at least half 
of the top-fifty tBLASTx hits against NCBI nucleotide collection). We also removed genes 
that appeared to have a complete ORF but encoded a protein that did not show the correct 
topology: seven TM domains flanked by an extracellular N-terminus and an intracellular 
C-terminus (determined by TMHMM2.0) (Sonnhammer et al., 1998). To complement 
the topologies calculated by TMHMM2.0, we inspected the posterior probability graphs 
generated by the program looking for potential TM domains that did not pass the 50% 
threshold to be automatically reported. After a second round of receptor mining and 
filtering, a set of 566 GPCR genes was finalized for downstream analyses. See Figure 3.1A 
for the workflow. Additional recursive searches did not expand the number of putative 
receptors, suggesting that our database contains nearly all of the expressed GPCR genes 
and the possibility of a significant number of unidentified GPCRs is slim.
Classification of planarian GPCRs
Initial compartmentalization of the planarian GPCRs was done by calculating an 
all-against-all similarity matrix of the 566 sequences that was then reduced to three-di-
mensional similarity networks. Human, insect, and nematode GPCRs were also included 
in parallel analyses to aid with identifying functional categories (Figure 3.1B). BLASTP 
was used to generate the similarity matrix, which was then analyzed by CLANS 2.0 (Fric-
key and Lupas, 2004) to determine the three-dimensional or two-dimensional cluster 
representation. CLANS 2.0 was allowed to use similarities more significant than 1E-9 and 
cycle approximately 20000 times to optimize the graph. For the cross-species clustering, 
the E-value threshold was set at 1E-6. The planarian GPCR graph was subsequently ana-
lyzed to extract convex clusters of four or more genes with the attraction value limit set at 
0.5 standard deviation.
Next, we pooled the rhodopsin-like genes from the previous analysis and aligned 
them using ClustalW (Thompson et al., 2002) within CLC Genomics Workbench 7. We 
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then generated a phylogenetic tree by neighbor-joining method (Jukes-Cantor distance 
measure), with 1000 replicas to deduce bootstrap values. We used this tree to validate the 
clustering analysis results. Two small clusters, containing 13 and 5 genes, were merged 
with clusters Srfa and Srw, respectively, because they were bound within the representa-
tives of the parent cluster on the tree. On the other hand, cluster R1 was extracted from 
cluster Rho-C, because its members were more closely related to those of cluster R2 than 
the original cluster. Finally, gcr081, gcr089, gcr442, and gcr500 were moved from L1 to L2 
based on their positions on the phylogenetic tree.
NPY receptor phylogeny
The 16 putative NPY receptor genes were used to perform an alignment search 
against Reference Proteomes with the EMBL-EBI HMMER tool (http://www.ebi.ac.uk/
Tools/hmmer/). Representative hits with E-value < 1E-30 were aligned and phylogenetic 
trees were constructed. In a separate analysis, only the planarian NPY receptors and their 
parasitic flatworm homologs were used. ClustalW (within CLC Genomics Workbench 
7.0) was used to align amino acid sequences with default parameters. Trimming the diver-
gent regions of the alignment or using MUSCLE (Edgar, 2004) for aligning did not change 
the topology of the final tree (data not shown). The resulting alignments were subjected to 
phylogenetic analysis by Bayesian inference in MrBayes v.3.2 (Ronquist et al., 2012), using 
the Whelan and Goldman (WAG) evolutionary model (Whelan and Goldman, 2001) to 
construct a 50% majority rule tree and assign posterior probabilities to tree nodes. Mar-
kov Chain Monte Carlo (MCMC) analyses ran on two independent chains (default) for 
200,000 iterations and finished with an average standard deviation of split frequencies of 
0.01 or less. The first 25% of sampled trees were discarded as the burnin period. Phyloge-
netic trees were visualized by FigTree v.1.4 (http://tree.bio.ed.ac.uk/software/figtree/). All 
trees were rooted with a group of two human and two planarian amine receptors.
Receptor cloning
For the purpose of ISH and RNAi experiments, 500-1000 bp segments of the 
GPCR genes were amplified (primers in Saberi et al., 2016) using Platinum Taq DNA 
Polymerase (Invitrogen). Products were TA-cloned into pJC53.2 and sequenced to de-
termine the directionality of cloning. pJC53.2 allows for probe synthesis using SP6 or T3 
polymerases, as well as dsRNA synthesis using T7 polymerase (Collins et al., 2010).
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A number of full-length NPY receptor coding sequences were cloned into 
pcDNA3.1 for the purpose of in vitro receptor assays. Primers corresponding to 
npyr-1 (forward: ACAGGGATCCACCATGGATTTGTGTAAGGATAATC, reverse: 
TATAGAATTCAGGACGACGATACTTCACTTTTG), npyr-7 (forward: ACAGGGATC-
CACCATGAATTCTATGAAAAATC, reverse: TATAGAATTCATAAAGATGATATTTT-
GAATCTTC), npyr-8 (forward: ACAGGGATCCACCATGATTTTATCGAATGGC, 
reverse: TATAGAATTCAATTTACTAATCCAATATGAGAATC), ophis (forward: ACAG-
GGATCCACCATGGTTTTCTGTAGACTAAT, reverse: TATAGAATTCAATTTATC-
GTTGAAGATTG) were used to amplify from sexual planarian cDNA. Forward primers 
had an extension containing a BamHI site and a kozak sequence before the start codon, 
while reverse primers contained a stop codon followed by an EcoRI site. Resulting clones 
were sequenced from both ends to confirm completeness and directionality of the insert. 
Plasmids were purified by QIAGEN Plasmid Midi Kit before transfecting CHO cells.
Peptide synthesis
NPY-1 (LNEYFAIVGRPRF-amid), NPY-8 (PMFDSADAFRNYLRKLNNEYMIA-
GRPRF-amide), and scrambled NPY-8 (LFRMRFDAMKDELRANNNRYFIPSYPGA-am-
ide) were synthesized by New England Peptide (Gardner, MA). Peptides were designed 
and C-terminally amidated based on in silico prediction of their bioactive form after enzy-
matic processing (Collins et al., 2010). For each peptide, purity of >95% was confirmed 
through HPLC by the vendor. Peptides were soluble in pure water (aided by brief sonica-
tion if needed).
In vitro receptor-activation assay
In vitro receptor-activation assays were done as previously described (Janssen et 
al., 2008). Briefly, calcium responses were measured in CHO-K1 cells transiently trans-
fected with a receptor::pcDNA3.1 construct of interest. Cells also stably expressed the 
promiscuous Gα16 protein and mitochondrially targeted apoaequorin. After loading with 
the cofactor coelenterazine, transfected cells were challenged with synthetic peptides 
(>95% purity) and calcium responses were simultaneously monitored on a Mithras LB940 
luminometer. In each case, calcium responses evoked by peptides were normalized to the 
total calcium response (i.e., response evoked by the peptide plus response evoked by a 
second addition of 0.1% Triton X-100). For concentration-response curves, the normal-
ized calcium responses are plotted as a percentage of the highest normalized response of 
the concentration series. Data were averaged from at least two independent experiments. 
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Dose-response curves constructed with a nonlinear regression analysis using a sigmoidal 
dose-response equation in Sigmaplot 12.0.
In situ hybridization
Whole-mount ISH was performed with a formaldehyde-based fixation proce-
dure as previously described (King and Newmark, 2013). The protocol was optimized for 
larger sexual planarians: formaldehyde fixation was increased to 30 minutes, proteinase 
K treatment was increased to 30 minutes, and post-fixation was increased to 20 minutes. 
Colorimetric and FISH samples were imaged on an Axio Zoom.V16 and a Zeiss LSM 710 
confocal microscope (Carl Zeiss, Germany), respectively. ISH probes were synthesized 
according to the methods previously described (King and Newmark, 2013). Single-strand-
ed RNA probes for Smed-gH4 (GB: DN306099) and Smed-npy-8 (GB: BK007010) were 
labeled with fluorescein isothiocyanate (FITC), for Smed-nanos (GB: EF035555) and 
Smed-npyr-1 with dinitrophenol (DNP), and for Smed-pc2 (GB: BK007043), Smed-ChAT 
(PlanMine, dd_Smed_v6_6208), and all of the analyzed GPCR genes by digoxigenin 
(DIG). For some FISH experiments, FITC or DNP probes for npyr-1 and ophis were 
synthesized. Probes were detected by corresponding HRP-conjugated antibodies and de-
veloped by 5-carboxytetramethylrhodamine (5-TAMRA), fluorescein amidite (FAM), or 
DyLight 633.
RNA-seq expression analyses
Approximately 400,000 reads from 12 independent control samples (6 sexual 
and 6 asexual worms) were mapped to the GPCR database using 0.9 as minimum sim-
ilarity and coverage fractions. Base 2 logarithm of the RPKM values (Mortazavi et al., 
2008) were used as a relative measure of expression comparing the two species. False 
Discovery Rate-corrected p-values (Benjamini and Hochberg, 1995) smaller than 0.05 
were considered significant. Read mapping and statistical analyses were performed using 
CLC Genomics Workbench 7. Because sexual planarians express sexually enriched GP-
CRs at very high levels compared to asexuals (increasing the denominator in the RPKM 
fraction), other GPCRs falsely appear to be enriched in asexuals. To correct this bias, we 
graphed log2(fold change) against log10(RPKM) for the 376 GPCRs with significant p-val-
ues. We then calculated a linear regression trend line for the middle 282 (75%) data points 
and used it to transform all fold change values so that the majority of them are around 
zero. The following transformation was applied: normalized log2(fold change) = original 
log2(fold change) - (0.411 * log10(RPKM)) + 2.29.
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Quantitative PCR
Total RNA was extracted from whole individual worms using TRIzol Reagent 
(Invitrogen) according to the manufacturer’s instructions, using the high-salt step for 
RNA precipitation. RNA was DNAse-treated, purified, and concentrated using the 
DNA-free RNA kit (Zymo Research). About 1 µg total RNA was used to prepare cDNA 
using iScript cDNA Synthesis Kit (Biorad) according to the kit protocol. GoTaq qPCR 
Master Mix (Promega) was used for qPCR reactions in a StepOnePlus Real-Time PCR 
machine (Applied Biosystems). Smed-beta-tubulin was used as an internal control. The 
following primers were used: npy-8-fwd TGACTCAGCTGATGCCTTTC, npy-8-rev 
GCCAAATCTTGGTCTTCC, npyr-1-fwd ACGACATTCAACGACAGAGG, npyr-1-rev 
GTAACGACATCGGACCAACA, nanos-fwd CAAGGACAAATGTTGCCTGTA, nanos-
rev CAACCCATCGATCCAACTCT, bTub-fwd TGGCTGCTTGTGATCCAAGA, bTub-
rev AAATTGCCGCAACAGTCAAATA. Three technical replicates were assayed for each 
sample. At least four individual animals were used as biological replicates for each con-
dition tested, unless mentioned otherwise. For each gene, ΔCt was calculated as the dif-
ference between Ct values of the gene of interest and beta-tubulin. Error bars indicate the 
range of relative quantities calculated from ΔΔCt ± SEM, where SEM is the standard error 
of the mean of ΔCt values of the test (and not the reference) biological replicates.
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